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Streptomyces coelicolor produces fatty acids for both primary metabolism 
and for production of the components of natural products such as 
undecylprodiginine. Primary metabolism makes the longer and predominantly 
branched-chain fatty acids, while undecylprodiginine utilizes shorter and almost 
exclusively straight chain fatty acids. The first step in fatty acid biosynthetic 
process is catalyzed by FabH (β-ketoacyl synthase III), which catalyzes a 
decarboxylative condensation of an acyl-CoA primer with malonyl-acyl carrier 
protein (ACP). The resulting 3-ketoacyl-ACP product is reduced by NADPH-
dependent FabG into 3-hydroxyacyl-ACP, which is dehydrated by FabA to form 
enoyl-ACP. The NADH-dependent FabI (InhA) completes the cycle. Subsequent 
rounds of elongations in the pathways are catalyzed by the condensing enzyme 
FabF. For undecylprodiginine biosynthesis in S. coelicolor, homologues of the 
condensing enzymes (FabH and FabF) and the ACP (FabC) are encoded by 
redP, redR and redQ respectively in the red gene cluster. The genes encoding 3-
ketoacyl-ACP reductase (FabG), 3-hydroxyacyl-ACP dehydratase (FabA), and 
enoyl-ACP reductase (FabI), are putatively shared between fatty acid and 
undecylprodigine biosynthesis, since the corresponding genes are not present 
within the red gene cluster of S. coelicolor. RedP is proposed to initiate 
biosynthesis of undecylprodiginine alkane chain by condensing an acetyl-CoA 
with a malonyl-RedQ, in contrast to FabH which process a broad range of acyl-
CoA with malonyl-FabC The 3-keto group of the resulting 3-ketoacyl-RedQ is 
then reduced to provide butyryl-RedQ, presumably by the type II FAS enzymes 
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FabG, FabA and FabI. These enzymes would not differentiate between straight 
and branched-chain substrates, and have equal preference for FabC and RedQ 
ACPs. RedR would then catalyze four subsequent elongation steps with malonyl-
RedQ, with appropriate 3-keto group processing after each step. The proposed 
role and substrate specificities of condensing enzymes RedP and FabH have not 
been investigated in S. coelicolor. The genes encoding FabG, FabA, and FabI 
have not been characterized in Streptomyces. Analysis of the S. coelicolor 
genome sequence has revealed the presence of one fabI gene (SCO1814, 
encoding an enoyl-ACP reductase), and three likely fabG genes (SCO1815, 
SCO1345, and SCO1346, encoding β-ketoacyl-ACP reductase).  
In the current study the substrates specificities of both RedP and FabH 
were determined from assays using pairings of two acyl-CoA substrates (acetyl-
CoA and isobutyryl-CoA) and two malonyl-ACP substrates (malonyl-RedQ and 
malonyl-FabC) (FabC is a dedicated ACP for fatty acid biosynthesis and RedQ for 
undecylprodiginine biosynthesis in S. coelicolor). For RedP, activity was only 
observed with a pairing of acetyl-CoA and malonyl-RedQ. No activity was 
observed with isobutyryl-CoA consistent with the proposed role for RedP and the 
observation that acetyl CoA-derived prodiginines predominate in S. coelicolor. 
Malonyl-FabC is not a substrate for RedP, indicating that ACP specificity is one of 
the factors that permit a separation between prodiginine and fatty acid biosynthetic 
processes. In contrast to RedP, FabH was active with all pairings but 
demonstrated the greatest catalytic efficiency with isobutyryl-CoA using malonyl-
FabC. Lower catalytic efficiency was observed using an acetyl-CoA and malonyl-
 iii 
FabC pairing consistent with the observation that in streptomycetes, a broad 
mixture of fatty acids are biosynthesized, with those derived from branched chain 
acyl-CoA starter units predominating. Diminished but demonstrable FabH activity 
was also observed using malonyl-RedQ, with the same preference for isobutyryl-
CoA over acetyl-CoA, completing biochemical and genetic evidence that in the 
absence of RedP this enzyme can also play a role in prodiginine biosynthesis, 
producing branched alkyl chain prodiginines. 
The identification and characterization of both enzymes FabG and FabI 
was also carried out. A series of straight and branched-chain β-ketoacyl and enoyl 
substrates tethered to either NAC or ACP were synthesized and used to elucidate 
the functional role and substrate specificity of these enzymes. Kinetic analysis 
demonstrates that of the three S. coelicolor enzymes, SCO1815 and SCO1345 
have NADPH-dependent β-ketoacyl-reductase activity, in contrast to SCO1346, 
which has NADH-dependent β-ketoacyl-reductase activity. Spectrophotometric 
assays revealed that all three FabGs are capable of utilizing both straight and 
branched-chain β-ketoacyl-NAC substrates. These results are consistent with 
FabGs role in fatty acid and undecylprodiginine biosynthesis, wherein it processes 
branched-chain for primary metabolism as well as straight-chain products for 
undecylprodiginine biosynthesis. LC/MS assays demonstrate that these FabG 
enzymes do not discriminate between primary metabolism ACP (FabC) and 
secondary metabolism ACP (RedQ) (except for SCO1345, which does not have 
any activity with RedQ). This relaxed substrate specificity allows these enzymes to 
process 3-ketoacyl-FabC substrates for fatty acid biosynthesis as well as 3-
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ketoacyl-RedQ substrates for undecylprodiginine biosynthesis. Similar to FabG, 
spectrophotometric and LC/MS assays were also carried out to elucidate the 
functional role and substrate specificity of S. coelicolor FabI. The kinetic analyses 
demonstrate that SCO1814 has NADH-dependent enoyl-ACP reductase activity. 
Spectrophotometric and LC/MS assays demonstrated that FabI does not 
differentiate between straight and branched-chain substrates, and has equal 
preference for FabC and RedQ ACPs. These observations provide experimental 
support for the hypothesis that these enzymes are shared and process the 
intermediates in the elongation cycle of both fatty acid and undecylprodiginine 
biosynthesis. In summary, these studies have demonstrated the activity of 
enzymes RedP, FabH, FabG and FabI (InhA) previously uncharacterized in S. 
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1.1 General introduction to Streptomyces and secondary metabolites 
 Streptomycetes are Gram-positive filamentous bacteria, which belong to 
the order Actinomycetales. This genus is characterized with high G+C content in 
their genome and a complex life cycle [1]. They are among the most abundant 
and wide-spread soil bacteria playing an important role in the breakdown of 
biological polymers such as lignocellulose, chitin and proteins that makes them 
central organism in carbon recycling. For years Streptomyces have been center 
of research and discussion because of their complex mycelium life cycle, which 
involves morphological differentiation and ability to produce secondary 
metabolites that have a wide range of biological activities in human medicine [2-
4]. Streptomyces is the largest antibiotic producing genus, it has been estimated 
that they produce approximately 70% of the world’s known antibiotics, as well as 
a wide range of other bioactive compounds such as antimalarial, 
immunosuppressant, anticancer agents, etc. These natural products are 
synthesized in complex secondary metabolic pathways; there is much interest to 
understand how these pathways are regulated and what influences the 
secondary metabolites productivity, as it is expected that this may lead to 
improving industrial process and also improve our understanding of secondary 




1.2 The Life Cycle of Streptomyces  
The Streptomyces life cycle begins with the germination of a single spore 
under favorable conditions to form hyphae (Fig 1) [4]. Growth and branching of 
the primary hyphae lead to the formation of a substrate mycelium. Subsequently 
in response to nutrient depletion and other signals, some hyphae start growing 
away from the surface to form the aerial mycelium. Aerial growth coincides with 
the initiation of both production of secondary metabolites and morphological 
differentiation [5]. When growth of the aerial mycelium stops, they develop septa 
which include one nucleoid per cell compartment. Each cellular compartment of 
the separated aerial hyphae matures into a grey-pigmented spore. 
Figure 1. The Life Cycle of Streptomyces  
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1.3 Fatty acid biosynthesis in Streptomyces coelicolor 
Fatty acids are one of the most important building blocks of cellular 
materials. In bacterial cells, fatty acids occur mainly in the cell membranes as the 
acyl constituents of phospholipids. Fatty acid synthesis (FAS) is a vital facet of 
cell physiology. In nature, there are two basic types of FAS architectures. The 
prototypical FAS I is found in mammals and consists of a single gene that 
produces a polypeptide, which contains all of the reaction centers required to 
produce a fatty acid. FAS II is found in most bacteria and plants, it is a 
dissociated system wherein each component is encoded by a separate gene that 
produces a unique protein, which catalyzes a single step in the pathway [6].  
Streptomycetes, like many other bacteria, utilizes a type II FAS to catalyze 
the formation of fatty acids. The majority of their fatty acids are made from 
branched-chain starters such as isobutyryl, isovaleryl and anteisovaleryl units to 
give odd- and even-numbered fatty acids with a methyl branch chain at the w-
terminus (80 to 90% of total fatty acid contents), the remainder are synthesized 
from straight chain starters such as acetyl and propionyl units [7-9] 
Initiation of a type II FAS process involves a direct condensation of an 
acyl-CoA with malonyl-ACP to form 3-ketoacyl-ACP (Fig. 2). This condensation is 
catalyzed by 3-ketoacyl-ACP synthase (FabH). The 3-ketoacyl-ACP product is 
processed through two reductive and one dehydration steps to generate acyl-
ACP. First, FabG, a nicotinamide adenine dinucleotide phosphate (NADPH) 
 4 
dependent 3-ketoacyl-ACP reductase reduces the 3-keto group and gives rise 3-
hydroxyacyl-ACP intermediate. Second, this intermediate is dehydrated by the 3-
hydroxylacyl-ACP dehydratase, known as FabZ or FabA. The third step involves 
the reduction of the enoyl-ACP by the NADH-dependent enoyl-ACP reductase 
(FabI) to complete the cycle. Subsequent rounds of elongations in the pathways 
are catalyzed by the condensing enzymes FabF or FabB. These enzymes 
condense the growing acyl-ACP with malonyl-ACP to extend the fatty acid chain 
by two carbons.  
 
 
Figure 2. Fatty acid biosynthesis by a type II fatty acid synthase. 
 
Malonyl-ACP used for each of the elongation steps of fatty acids 
biosynthesis is derived from malonyl-CoA by the action of malonyl-CoA: ACP 
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transacylase (FabD). All the reaction intermediates (growing acyl-chains) in the 
fatty acid biosynthesis are covalently attached to the acyl carrier protein (ACP) 
through a thioester linkage to the sulphydryl of the 4’-phosphopanteine prosthetic 
group. 
Streptomycetes are unusual bacteria not only because of the complexity 
of their life-cycle but also because of their ability to produce an array of 
secondary metabolites (organic molecules that are not directly involved in the 
normal growth and development of an organism). These secondary metabolites 
possess interesting pharmacological properties and widely used in human health 
as antibacterial, anticancer, and antifungal agents. Also, in agriculture these 
compounds acts as growth promoters, antiparasitic agents and herbicides. This 
novel characteristic makes the streptomycetes not only interesting organisms for 
research, but also commercially important. 
1.4 Undecylprodiginine biosynthesis in Streptomyces coelicolor. 
Undecylprodiginine is one of a number of secondary metabolites produced 
by S. coelicolor, one of the best genetically characterized streptomycetes [11]. It 
is a tripyrrole red pigmented compound with a linear alkyl chain, which have 
gained much attention because of its wide range of biological activities such as 
antibacterial, immunosuppressive, antimalarial, and anticancer [12,13]. It has 
been demonstrated that the 23 red genes in S. coelicolor encode a fascinating 
and unusual pathway leading to formation of undecylprodiginine (Fig. 3). 
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Undecylprodiginine biosynthetic process occurs via a complex interface with 
primary metabolism and involves numerous multifunctional proteins with unusual 
architecture and catalytic activities. The biosynthesis of undecylprodiginine 
proceeds via a bifurcated pathway in which 2-undecylpyrrole (UP) and 4-
methoxy-(2,2’-bipyrrole)-5-carboxaldehyde (MBP) are first assembled and then 
coupled (Fig. 4). Six of the 23 genes in the cluster (redP, redQ, redR, redJ, redL, 
and redK) have been proposed to be involved in the formation of the 2-
undecylpyrrole. Of these, redP, redR and redQ encoded homologs of the type II 
fatty acid synthases FabH (KASIII) and FabF (KASII) enzymes and an acyl 
carrier protein (ACP) respectively [14]).  
 
 
Figure 3. The undecylprodiginine biosynthetic gene cluster in S. coelicolor A3(2). 
 
It has been proposed that RedP and RedR, in tandem with fatty acid 
biosynthetic enzymes, which catalyze the conversion of 3-ketoacyl-ACP to acyl-
ACP, are responsible for formation of a RedQ-activated dodecanoic acid (Fig. 4). 
RedP is proposed to initiate the biosynthetic process by condensing an acetyl-
CoA starter unit with a malonyl-RedQ (ACP). The 3-keto group of the resulting 
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acetoacyl tioester would be reduced to provide butyryl-RedQ, presumably by the 
type II FAS enzymes (FabG, FabA and FabI). RedR might catalyze four 
subsequent elongation steps with malonyl-RedQ, and with appropriate 3-keto 
group processing after each step. RedJ, a thiosterase catalyzes the hydrolysis of 
dodecanoyl-RedQ to provide dodecanoic acid, which is elongated by the action 
of RedL generate 4-keto-2-undecylpyrroline. RedJ has been demonstrated to 
have much greater activity with longer chain acyl substrates (up to C10 in length) 
and to efficiently discriminate between acyl-RedQ substrates and other acyl-
ACPs [15]. The final step in the biosynthesis of 2-undecylpyrrole is the reduction 
and dehydration of 4-keto-2-undecylpyrroline, catalyzed by RedK.  
 
 
Figure 4. Proposed bifurcated biosynthetic pathway of the undecylprodiginine. 
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This ACP selectivity is thus observed at both the first (RedP) and last step 
(RedJ) in formation of dodecanoic acid for prodiginine biosynthesis, and 
presumably plays a key role in keeping this process and the fatty acid biosynthetic 
process separate. 
The first steps in the biosynthesis of MBP involve the incorporation of 
proline to form the pyrrole ring catalyzed by RedM, RedO and RedW. 
Subsequent steps in MBP biosynthesis involve an elongation of the activated 
pyrrole-2-carboxylic acid via a decarboxylative condensation with malonyl-CoA 
and L-serine to generate 4-hydroxy-2,2’-biopyrrole-5-methanol (HBP), and is 
likely catalyzed by RedX and RedN. The final steps in MBP biosynthesis are a 
methylation catalyzed by the S-adenosylmethionine dependent RedI and an 
oxidation by RedV. The last step in the biosynthesis of undecylprodiginine is the 
RedH catalyzed-condensation between the UP with MBP to form the tripyrrole 
pigment. 
1.5 The interface between fatty acid and undecylprodiginine biosynthesis in 
S. coelicolor 
Secondary metabolites are generally synthesized in dedicated 
biosynthetic pathways, but these are linked to the primary metabolism through 
the use of specific precursors, various cofactors, and even shared enzymes. 
Although detailed knowledge is unclear, the link between primary and secondary 
metabolism has been repeatedly observed [16-18]. The fatty acid biosynthetic 
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pathway that provides the undecyl chain of the undecylprodiginine in S. 
coelicolor, gives an opportunity to study one such instance at a genetic and 
biochemical level. In order to further evaluate the link between primary and 
secondary metabolism we decided to study the enzymes that are proposed to be 
separate (FabH and RedP) and common (FabG, and FabI) to both fatty acid and 
undecylprodiginine biosynthesis (Fig. 5). The overall objective of this study is to 
build a compressive understanding of the enzymology of both bacterial FAS and 
undecylprodiginine biosynthetic processes and the interface between them. 
 
Figure 5. Proposed interface between fatty acid and undecylprodiginine 
biosynthesis in S. coelicolor.  
1.6 Aims of the current research 
The proposed role and substrate specificity (both acyl-CoA and ACP 
specificities) of condensing enzymes RedP and FabH have not been investigated 
in S. coelicolor. We posited that a) FabH and its homologue RedP, which 
catalyze the initial condensation in fatty acid and undecylprodiginine biosynthesis 
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respectively, should be highly selective for either straight (RedP) or branched-
chain (FabH) acyl-CoA substrates b) both enzymes should also possess differing 
ACP specificities. This combination of acyl-CoA and ACP specificity will 
presumably play a key role in keeping these two processes separate.  
The genes encoding FabG, and FabI, putatively shared between primary 
and secondary fatty acid synthesis, have also not been characterized in 
Streptomyces. Analysis of the S. coelicolor genome sequence has revealed the 
presence of one fabI gene (SCO1814, encoding a putative enoyl-ACP 
reductase), and three likely fabG genes (SCO1815, SCO1345, SCO1346, 
encoding putative β-ketoacyl-ACP reductase). We hypothesized that a) the FabI 
(encoded by SCO1814) and the putative FabG (encoded by SCO1815, which 
lies immediately adjacent to fabI) would have enoyl-ACP reductase and 3-
ketoacyl-ACP reductase activity respectively and b) that neither would show 
selectivity for the ACP substrate (FabC or RedQ), or the branching in the acyl 
chain. This activity would permit them to process the acyl chains for both the 
primary and secondary metabolism and would contrast the initiation enzyme 
selectivity. We also posited that of the three possible FabG only one (SCO1815) 
should have ketoreductase activity, as it is cluster with FabI similar to the other 
organism such as M. tuberculosis, M. smegmatis [19]. Accordingly the catalytic 
activity and substrate specificity of the other two FabG homologs (encoded by 
SCO1345 and SCO1346) might be dramatically different if their biological role is 
unrelated to fatty acid biosynthesis.  
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We have tested these hypotheses through the following three specifics 
aims: 
1. Determine the substrate specificities of the primary metabolic enzyme (FabH) 
and its homolog (RedP), which catalyze the first step in the formation of fatty acid 
and undecylprodiginine biosynthesis respectively.  
2. Identify and characterize of β-ketoacyl-ACP reductase (FabG) which catalyzes 
the reduction of 3-ketoacyl-ACP to 3-hydroxyacyl-ACP in both processes. 
3. Identify and characterize of enoyl-ACP reductase (FabI or InhA) which 











2.0 Determine the substrate specificities of the primary metabolic enzyme 
(FabH) and its homolog (RedP) which catalyze the first step in the 
formation of fatty acid and undecylprodiginine biosynthesis respectively. 
2.1 Summary 
RedP is proposed to initiate undecylprodiginine biosynthesis in 
Streptomyces coelicolor by condensing an acyl-CoA with malonyl-ACP, and is 
homologous to FabH which catalyzes the same reaction for initiation of fatty acid 
biosynthesis. Herein, we report the substrate specificities of RedP and FabH from 
assays using pairings of two acyl-CoA substrates (acetyl-CoA and isobutyryl-CoA) 
and two malonyl-ACP substrates (malonyl-RedQ and malonyl-FabC). RedP 
activity was observed only with a pairing of acetyl-CoA and malonyl-RedQ, 
consistent with its proposed role in initiating formation of acetyl CoA-derived 
prodiginines. Malonyl-FabC is not a substrate for RedP, indicating that ACP 
specificity is one of the factors that permit a separation between prodiginine and 
fatty acid biosynthetic processes. FabH demonstrated greater catalytic efficiency 
for isobutyryl-CoA in comparison to acetyl-CoA using malonyl-FabC, consistent 
with the observation that in streptomycetes, a broad mixture of fatty acids is 
synthesized, with those derived from branched chain acyl-CoA starter units 
predominating.  Diminished FabH activity was also observed using malonyl-RedQ 
with the same preference for isobutyryl-CoA, completing biochemical and genetic 
evidence that in the absence of RedP this enzyme can produce branched alkyl 
chain prodiginines. 
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2.2 Introduction  
Plants and bacteria use a dissociated type II fatty acid synthase (FAS) to 
generate fatty acids [20]. The first step in this process is catalyzed by FabH, which 
catalyzes a decarboxylative condensation of an acyl-CoA primer with malonyl-acyl 
carrier protein (ACP). The resulting 3-ketoacyl-ACP product is processed by the 






























































Figure 6. Proposed role of FabH and RedP in initiating biosynthesis of fatty acids 
(A) and undecylprodiginine (B) in Streptomyces coelicolor. The type II FAS is 
responsible for subsequent conversion of 3-ketoacyl-ACP products to an acyl-
ACP. A subsequent decarboxylative condensation with malonyl-ACP by either 
FabF or RedR elongates the acyl chain. The alkyl group (R) is typically C1–C5 and 
can be straight or branched. 
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FabH enzymes exhibit different acyl-CoA specificities. For organisms which 
generate only straight chain fatty acids (such as Escherichia coli), the FabH has 
been shown to be specific for acetyl-CoA [21]. Many microorganisms, including 
bacilli and streptomycetes generate predominantly branched chain fatty acids [22]. 
These fatty acids are generated typically using isobutyryl-CoA, and methylbutyryl-
CoA starter units and FabH from some of these organisms has been shown to use 
these as substrates in addition to acetyl-CoA. Crystal structures of numerous 
FabH enzymes and examination of their acyl binding pockets has provided a 
structural insight into the basis of this substrate specificity [23-25]. 
A dramatic shift, from predominantly branched-chain fatty acids to straight 
chain fatty acids, has been reported for the lipid profile of a S. coelicolor YL1 
mutant, in which the natural FabH is replaced by the E. coli FabH [26]. This 
observation has provided clear evidence that the substrate specificity of a FabH 
plays a pivotal role in determining the type of fatty acid made by an organism.  
In streptomycetes, FabH enzymes are also found in processes which 
generate secondary metabolites such as frenolicin, hedamycin, R1128 and 
undecylprodiginine [27-30]. Undecylprodiginine, a tripyrrole red pigmented 
compound, is known to exhibit a wide range of biological activities such as 
antibacterial, immunosuppressive, antimalarial, and anticancer [31, 32]. For its 
biosynthesis in S. coelicolor, a FabH and a FabC homolog are encoded by redP 
and redQ in the undecylprodiginine biosynthetic gene cluster. It has been 
proposed that RedP catalyzes a decarboxylative condensation between acetyl-
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CoA and malonyl-RedQ, as the first step in generating dodecanoic acid (Fig. 6) 
[30]. This intermediate is then used to generate the alkyl side chain of the final 
undecylprodiginine product. A ΔredP mutant (SJM1) has been shown to produce 
about 80% less of this product and to produce very low levels of new branched-
chain alkyl prodiginines (the straight chain prodiginine product predominates). 
Evidence that in SJM1, undecylprodiginine biosynthesis is initiated by the fatty 
acid synthase FabH was provided by observation that higher levels of this enzyme 
led to a partial restoration of overall prodiginine yields [33]. 
The observations of fatty acid and prodiginine biosynthesis by the S. 
coelicolor wild type, and the YL1 and SJM1 mutants raise several questions 
regarding the role and specificities of RedP and FabH. For RedP, the proposed 
preference for acetyl-CoA and malonyl-RedQ has not been investigated. For 
FabH, the initial characterization of the S. glaucescens FabH (which has 100% 
amino acid sequence identity with S. coelicolor FabH) demonstrated comparable 
enzyme efficiencies for isobutyryl-CoA and acetyl-CoA. A preference for branched 
chain acyl-CoA substrates would be predicted given that the corresponding long 
chain fatty acids predominate in S. coelicolor (and are almost completely lost in 
the YL1 mutant) and that there is no evidence that these substrates are present at 
higher intracellular concentrations than acetyl-CoA in the cell. On the other hand, 
a FabH preference (or tolerance) for branched chain acyl-CoA substrates, does 
not readily explain why it initiates formation of predominantly acetyl-CoA derived 
prodiginines in the SJM1 mutant. 
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In the aim 1 we have characterized with respect to substrate specificity 
(both acyl-CoA and ACP specificities) of both the S. coelicolor RedP and FabH 
enzymes. Kinetic studies demonstrate that RedP is specific for the straight chain 
acetyl-CoA, and FabH for the branched chain isobutyryl-CoA. Additionally both 
enzymes are shown to have differing ACP specificities. These data provide 
answers to the questions arising from analyses of the YL1 and SJM1 mutants 
2.3 Materials and methods  
Materials. [1-14C]Acetyl-CoA (60.4 mCi/mmol) was purchased from Moravek 
Biochemicals, and  [1-14C]isobutyryl-CoA (55 mCi/mmol) was obtained from 
American Radiolabeled Chemicals Inc. Cosmids 3F7 and 4A7 containing S. 
coelicolor genomic DNA were kindly provided by the John Innes Institute.  
Construction of expression Plasmids. The redP gene was amplified from 3F7 
cosmid using the forward primer 5’-CGTGCATGCATATGACCCGGGCGTCCGT-
3’ and the reverse primer,  
5’-GCTACTCGAGGACCGGATCGACGGCGG-3’. The scfabD gene was amplified 
from 4A7 using the forward primer 5’-GACTCATATGCTCGTACTCGTCGCTCC-3’ 
and the reverse primer 5’-GATTACTCGAGTCAGGCCTGGGTGT-3’ (restriction 
sites are underlined). The redP gene was cloned into expression vector pET28a 
to construct the plasmid pSJM3 and the scfabD gene was cloned into expression 
vector pET15b to give pSJM5.  
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Protein expression and purification. Both plasmids were used to transform E. 
coli BL21(DE3) cells. The resulting transformants were grown at 37 oC in LB 
medium containing either 50 μg mL-1 kanamycin for pSJM3 or 100 μg mL-1 
ampicillin  for pSJM5 to an A600 = 0.6, induced with 0.1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) and incubated for approximately 12 h at 30 oC. 
Cells were harvested by centrifugation at 12, 000 g for 10 min, at 4 oC and cell 
pellets were stored at -80 oC. 
The appropriate E. coli cell pellets were suspended in lysis buffer-A (50 
mM sodium phosphate buffer pH 7.2, 300 mM NaCl, 5 mM 2-mercaptoethanol, 10 
% glycerol, 0.05 %(v/v) Tween-20) with 10 mM imidazole and lysozyme (1 mg mL-
1). The resulting cell suspension was incubated on ice for 30 min and cell lysate 
was cleared by centrifugation at 16,000 g for 20 min. The crude cell extract was 
loaded onto a Ni-NTA resin column. His-tagged protein was eluted by using 
buffer-A with 300 mM imidazole. Fractions containing pure protein were pooled, 
exchanged with 50 mM sodium phosphate buffer pH 7.2, and stored in 20 % 
glycerol at -80 oC.  
Expression and purification of FabH, holo-FabC and holo-RedQ was 
carried out in a similar way as previously described [34-36]. 
Preparation of Malonyl-ACPs. The recombinant S. coelicolor His6-FabD was 
used to prepare malonyl-RedQ and malonyl-FabC (from holo-RedQ or holo-FabC) 
with a previously described protocol [22]. The purity of each malonyl-ACP product 
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was monitored using a microTOF-Q (QqTOF) (Bruker) mass spectrometer, with a 
similar method to that described previously [37].  
RedP and FabH assays. Enzyme activity was determined by monitoring 
conversion of radioactive acyl-CoA and malonyl-RedQ (or malonyl-FabC) 
substrates to a radiolabeled 3-ketoacyl-RedQ (or 3-ketoacyl-FabC) product using 
a standard TCA precipitation assay [22]. Briefly, the reaction mixture contained 50 
mM sodium phosphate buffer (pH 7.2), 1 mM dithiothreitol, 40.0 μM of malonyl-
RedQ (or malonyl-FabC), 40 μM [1-14C]acetyl-CoA (or [1-14C]isobutyryl-CoA) and 
0.1μg RedP (or FabH) in final volume of 20 μL. The reaction mixture was 
incubated at 30 oC for 10 min and terminated by the addition of 10% (w/v) 
trichloroacetic acid. Precipitation was completed by incubation on ice, and the 
precipitate was collected by centrifugation. The pellets were resuspended in 200 
μL of 2 % SDS in 20 mM NaOH. The suspension was combined with scintillation 
fluid and analyzed with a scintillation counter. Steady-state kinetic parameters for 
acetyl-CoA and isobutyryl-CoA were obtained by determination of RedP and FabH 
activity using various concentrations of [1-14C] acetyl-CoA (2.5 to 40 µM), or [1-
14C]isobutyryl-CoA (0.25 to 10.0 µM) and a constant concentration (30 µM) of 
either malonyl-RedQ or malonyl-FabC. Similarly, an apparent KM for malonyl-
RedQ and malonyl-FabC was obtained by using a constant concentration of either 
30 µM [1-14C] acetyl-CoA or 10 µM [1-14C]isobutyryl-CoA and variable 
concentrations of malonyl-RedQ (2.5 to 40 µM) and malonyl-FabC (1.0 to 25 µM).  
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2.4 Results and Discussion  
RedP Specificity. RedP and FabH were expressed as recombinant proteins in E. 
coli and purified by nickel-chelate affinity chromatography to yield homogenous 
enzymes of expected molecular mass (~37 kDa) based on sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) (Fig. 7).  
 
 
Figure 7. SDS-PAGE of the Ni-NTA purified FabH (Left) and RedP (Right). 
M-Standard protein marker; FL-Flow through; W-Wash; E-Protein elution fraction. 
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RedP and FabH were assayed using two acyl-CoA substrates (acetyl-CoA 
and isobutyryl-CoA) and two malonyl-ACP substrates (generated by FabD from 
RedQ and FabC using malonyl-CoA). The redQ gene has been predicted to 
encode a protein with ACP homology [30] and is directly adjacent to redP in the 
prodiginine biosynthetic gene cluster (Fig. 3); thus RedQ is a likely substrate for 
RedP. In contrast, the fabC gene product is unlikely to be a RedP substrate as 
this gene is located with fabH, fabF and fabD in S. coelicolor [37] and other 
streptomycetes, and all current data indicate that this provides the ACP for fatty 
acid biosynthesis. 
As predicted, RedP was active (Table 1) with an acetyl-CoA and malonyl-
RedQ pairing (kcat 1.52 min
-1, KM value for acetyl-CoA 10.35 ± 2.76 µM and for 
malonyl-RedQ 6.73 ± 0.31 µM). However no detectable activities were observed 
with any other pairing (limit of detection was < 1% of activity observed with acetyl-
CoA and malonyl-RedQ), demonstrating that neither isobutyryl-CoA nor malonyl-
FabC are substrates for RedP.  
These observations demonstrate a clear substrate preference of RedP and 
provide biochemical evidence to support the role of RedP catalyzing the first step 
in biosynthesis of the undecylpyrrole component of undecylprodiginine. The 
specificity for acetyl-CoA plays a key role in controlling formation of a straight-
chain dodecanoyl-ACP and thus formation of acetate-derived alkylprodiginines in 
S. coelicolor. The RedP specificity for malonyl-RedQ demonstrates that the 
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process to generate acetate-derived alkylprodiginines via a dodecanoyl-ACP (Fig. 
1) occurs using a dedicated ACP.  
Table 1. Kinetic data of RedP and FabH 
ND, not detectable  
 
We have recently demonstrated that RedJ is a thioesterase which can 
catalyze the hydrolysis of dodecanoyl-RedQ to provide dodecanoic acid [36], and 
genetic evidence has shown that it is converted to undecylpyrrole by the actions of 
RedL and RedK [38]. RedJ has been demonstrated to have much greater activity 
with longer chain acyl substrates (up to C10 in length) and to efficiently 
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discriminate between acyl-RedQ substrates and other acyl-ACPs. This ACP 
selectivity is thus observed at both the first (RedP) and last step (RedJ) in 
formation of dodecanoic acid for prodiginine biosynthesis, and presumably plays a 
key role in keeping this process and the fatty acid biosynthetic process separate. 
An 80% decrease in prodiginine production upon deletion of redP in S. 
coelicolor (SJM1) indicates that RedP is an important enzyme for prodiginine 
biosynthesis, but not essential [33]. A significant restoration of prodiginine 
biosynthesis is observed in SJM1 with plasmid-based expression of FabH, 
indicating that FabH can function in place of RedP. The specificity of RedP and 
RedJ for malonyl-RedQ would predict that in order to support prodiginine 
biosynthesis, FabH should be able to utilize malonyl-RedQ as well as malonyl-
FabC. 
FabH Specificity. The streptomycetes FabH was initially assayed using the E. 
coli ACP to generate the malonyl-ACP. The cognate ACP from streptomycetes 
(FabC) was not used in these assays. Isobutyryl-CoA was observed to have a 3-
fold slower Vmax than acetyl-CoA, and a lower KM [22]. In this study we sought to 
extend these analyses to include both the cognate ACP (malonyl-FabC) and 
malonyl-RedQ.  
 As shown in Table 1, a lower KM (1.74 µM) for isobutyryl-CoA than acetyl-CoA 
(8.36 µM) was also observed using malonyl-FabC. However, in this case the 
overall reaction rate (kcat) was 10-times faster for isobutyryl-CoA in comparison to 
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acetyl-CoA (Table 1 and Fig. 8). The FabH is approximately 50-fold more efficient 
using isobutyryl-CoA versus acetyl-CoA using malonyl-FabC, and provides a 
much a clearer demonstration of a) the role of the streptomycetes FabH in 
generating predominantly branched chain fatty acids, and b) the reason why 
replacement of S. coelicolor FabH with the acetyl-CoA specific E. coli FabH 
(YL1/ecFabH mutant) results in a dramatic shift to a fatty acid profile of 
predominantly straight chain fatty acids [26].  
As predicted, FabH was able to use malonyl-RedQ in place of malonyl-
FabC. Under saturating malonyl-RedQ conditions FabH was able to use either 
acetyl-CoA or isobutyryl-CoA (Table 1). The KM values for each of these were 
comparable to those observed using malonyl-FabC, and again there was almost a 
40-fold higher catalytic efficiency (kcat/KM) for isobutyryl-CoA compared to acetyl-
CoA. However for both acyl-CoA substrates the reaction rate kcat was at least 20-
fold less using malonyl-RedQ versus malonyl-FabC (Fig. 8).  
At fixed isobutryl-CoA and acetyl-CoA concentrations and variable malonyl-
RedQ or malonyl-FabC concentrations similar sets of observations were made. 
Greater catalytic efficiency was seen with isobutyryl-CoA relative to acetyl-CoA 
and for each acyl-CoA substrate the apparent reaction rate was much faster using 
malonyl-FabC than with malonyl-RedQ. This set of analyses also demonstrated 







Figure 8. Comparison of FabH activity for isobutyryl-CoA (A) and acetyl-CoA (B) 














































Thus the difference in overall catalytic efficiency of FabH using malonyl-
ACP substrates arises predominantly from differences in apparent catalytic rates 
rather than KM values. The ability of FabH to utilize malonyl-RedQ and to have a 
preference for isobutyryl-CoA is consistent with a) genetic data which suggest 
FabH can initiate prodiginine biosynthesis in SJM1, the S. coelicolor redP deletion 
mutant, and b) the observation of a significant increase in branched alkyl chain 
prodiginines in the SJM1 mutant relative to the wild type S. coelicolor [14]. A final 
observation from these analyses is that the maximal kinetic efficiency of FabH 
(kcat/KM of 9.84 µM
-1min-1 using isobutyryl-CoA and malonyl-FabC) is 66-fold 
higher than that of RedP (kcat/KM of 0.147 µM
-1min-1 using acetyl-CoA and malonyl-
RedQ). This difference might arise from the ability of FabH to utilize isobutyryl-
CoA (the enzymes have comparable efficiencies using acetyl-CoA), or because 
FabH is a primary metabolic enzyme. 
Role of ACP in apparent substrate specificity of FabH and RedP. Initial 
characterization of many FabH enzymes, including those from streptomycetes 
was carried out with a commercially available E. coli ACP [22, 39-41]. Subsequent 
work has revealed that these enzymes have ACP specificity. Improved catalytic 
activity and in some cases apparent changes in acyl group specificity can be 
observed when assays are performed using malonyl-ACP generated from the 
cognate ACP [23, 42]. In the case of the Mycobacterium tuberculosis FabH 
(mtFabH), which has a broad specificity for long chain acyl-CoA substrates, the 
preferred substrate is dodecanoyl-CoA using the E. coli FAS ACP, and 
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octadecanoyl-CoA using the M. tuberculosis FAS ACP enzyme [42]. In the current 
study, the streptomycetes FabH has been shown to have both a much greater 
difference in catalytic efficiency between isobutryryl-CoA and acetyl-CoA using 
FabC (the cognate ACP) than was initially observed using the E. coli ACP, and a 
much greater catalytic efficiency using malonyl-FabC than with malonyl-RedQ. In 
addition, RedP has been shown to effectively discriminate between malonyl-RedQ 
and malonyl-FabC, using only acetyl-CoA as a substrate.  
A recent model for FabH catalysis, based on experiments with the mtFabH, 
has indicated an open form of the enzyme which orders around the acyl-CoA 
substrate and leads to the formation of an acyl enzyme intermediate. In the case 
of the mtFabH, a long acyl binding pocket to accommodate acyl chains has been 
identified from the X-ray crystal structure analyses. imilar structural analyses have 
shown a small acyl binding pocket for the E. coli FabH, which is only able to utilize 
acetyl-CoA and propionyl-CoA substrates [43-45] and a slightly larger acyl binding 
pocket for the enzyme in Staphylococcus aureus, which uses branched substrates 
such as isobutyryl-CoA [43]. Thus it is the acyl binding channel which to some 
extent dictates FabH specificity. The data obtained in the current study would 
indicate that the acyl binding channel of RedP (which utilized only acetyl-CoA) is 
likely to be more restrictive than the corresponding binding channel of the 
streptomycetes FabH enzyme (which also could utilize isobutyryl-CoA).   
  The mtFabH model also provides a rationale for how steps subsequent to 
formation of the acyl-enzyme intermediate, involving the malonyl-ACP, also 
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contribute to the overall catalytic reaction rate and differing reaction rates for 
various acyl-CoA substrates. Reaction of the acyl-enzyme intermediate with the 
malonyl-ACP leads to formation of the 3-ketoacyl-ACP product and an open form 
of the enzyme which permits egress of the product via binding of the acyl group to 
an appropriate region of the ACP [44]. Under certain conditions this final step is 
the rate determining step and differences in the ability of ACPs to sequester the 
various acyl groups of the 3-ketoacyl-ACP products and to productively interact 
with the acyl-enzyme form of the FabH provides a basis for the observations 
regarding FabH specificity and activity. Thus if FabC can sequester branched 
chain acyl groups more effectively than the E coli ACP, much faster reactions will 
be observed using this as the malonyl-ACP substrate with the streptomycete 
FabH and isobutyryl-CoA. Slower overall rates observed with the Streptomycetes 
FabH using malonyl-RedQ, indicate it can bind productively with the activated 
FabH, but there is a slower rate-limiting product release. The higher catalytic rate 
for isobutyryl-CoA under these conditions would suggest that RedQ, like FabC, 
has the ability to sequester straight and branched acyl chains. Finally, if malonyl-
FabC cannot bind productively with the activated RedP, formation and release of a 
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3.0 Identification and characterization of β-ketoacyl-ACP reductase (FabG) 
and enoyl-ACP reductase (FabI) 
3.1 Summary. 
Streptomyces coelicolor produces fatty acids for both primary metabolism 
and for production of the natural product, undecylprodiginine. The fatty acids are 
predominantly branched-chain while undecylprodiginine utilizes almost 
exclusively a straight-chain dodecanoic acid. The first and last reductive steps 
during the chain elongation cycle of fatty acid biosynthesis are catalyzed by 
NADPH-dependent β-ketoacyl-acyl carrier protein reductase (FabG) and an 
NADH-dependent enoyl-ACP reductase (FabI or InhA). The Streptomyces 
coelicolor, FabG, and FabI, are presumed to be used in both processes, 
contrasting the condensing enzymes which allow the processes to be controlled 
for differentiated products. Analysis of the S. coelicolor genome sequence has 
revealed the presence of one fabI gene (SCO1814), and three likely fabG genes 
(SCO1815, SCO1345, and SCO1846). Here we report the expression, 
purification and characterization of the FabI and the three FabG homologs. A 
series of straight and branched-chain β-ketoacyl and enoyl substrates tethered to 
either an N-acetylcysteamine (NAC) or acyl carrier protein (ACP) were 
synthesized and used to elucidate the functional role and substrate specificity of 
these enzymes. Kinetic analyses demonstrate that of the three S. coelicolor 
enzymes SCO1815, and SCO1345 have NADPH-dependent β-ketoacyl-
reductase activity and SCO1346 has NADH-dependent β-ketoacyl-reductase 
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activity. Spectrophotometric assays revealed that all three FabGs are capable of 
utilizing both straight and branched-chain β-ketoacyl-NAC substrates. An LC/MS 
assay demonstrated that the FabGs encoded by SCO1815 and 1346 can 
process 3-ketoacyl-ACP substrates using ACPs involved in the fatty acid and 
undecylprodiginine biosynthetic processes (FabC and RedQ, respectively). This 
relaxed acyl and ACP substrate specificity allows these enzymes to process 
intermediates in both processes and provides the first experimental evidence for 
this role. Similarly, observations regarding NADH-dependant processing of 
straight and branched-chain enoyl-NAC substrates as well as enoyl-ACPs with 
different ACPs substrates, using the S. coelicolor FabI were made. These data 
represent the first reported analysis of a streptomycetes FabI and provide the 
first experimental evidence that both FabG and FabI catalyzed reductive steps in 
the fatty acid biosynthetic process are shared with that needed for 
undecylprodinine biosynthesis. 
3.2 Introduction 
Streptomycetes, like many other bacteria, utilize a type II fatty acid 
synthase to catalyze the formation of fatty acids. They produce primarily 
branched-chain fatty acids with only a minor portion of straight-chain fatty acids 
[46]. The first step in a type II fatty acid synthase (FAS) process is catalyzed by 
FabH (β-ketoacyl synthase III), which catalyzes a decarboxylative condensation 





Figure 9. Interface between fatty acid and undecylprodiginine biosynthesis in S. 
coelicolor.  
 
For branched-chain fatty acids the primer is typically either isobutyryl-CoA 
or methylbutyryl-CoA. For straight-chain fatty acids, acetyl-CoA and propionyl-
CoA serve as the most common primers. The resulting 3-ketoacyl-ACP product 
is reduced by NADPH-dependent FabG to provide 3-hydroxyacyl-ACP, which is 
dehydrated by FabA to form enoyl-ACP. The NADH-dependent FabI completes 
the cycle by catalyzing a reduction to provide the corresponding acyl-ACP. In 
subsequent rounds of elongation the condensation step using the acyl-ACP is 
catalyzed by FabF rather than FabH, which only catalyzes the chain initiating 
step. The malonyl-ACP utilized in each elongation step is generated from 
malonyl-CoA by the action of a malonyl CoA:ACP transacylase (encoded by 
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fabD). In streptomycetes the fabH, fabC (encoding the ACP), fabF and fabD are 
clustered together as an operon [47]. 
Streptomycetes also produce a vast array of biologically active secondary 
metabolites widely used in human health such as antibacterial, 
immunosuppressant, anticancer and antimalarial [48], and in a number of cases 
these natural products use fatty acids as a building block. These fatty acids often 
differ in chain length or extent of branching from those made by the primary 
metabolic type II FAS (e.g. daptomycin, frenolicin, R1128, tunicamycin, and 
undecylprodiginine [49-54]. The biosynthesis of their alkane chain occurs by a 
type II FAS pathway which must differ from the primary metabolic pathway in the 
type of acyl precursors and number of cycles used. One such example is 
undecylprodiginine, it is a tripyrrole red pigmented compound with a linear alkyl 
chain, known to exhibit a wide range of biological activities such as antibacterial, 
immunosuppressive, antimalarial, and anticancer [55,56]. 
Studies have revealed that the control of the two processes providing fatty 
acids for primary and secondary metabolism lies partially in the initial condensing 
enzymes [46, 57, 58]. For undecylprodiginine biosynthesis in S. coelicolor, 
homologues of the condensing enzymes (FabH and FabF) and the ACP (FabC) 
are encoded by redP, redR and redQ respectively in the red gene cluster. RedP 
is proposed to initiate biosynthesis of undecylprodiginine’s alkane chain by 
condensing an acyl-CoA with a malonyl-RedQ. The 3-keto group of the resulting 
3-ketoacyl-RedQ is then reduced to provide butyryl-RedQ, presumably by the 
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type II FAS enzymes FabG, FabA and FabI. RedR would then catalyze the 
subsequent condensation steps with malonyl-RedQ, and type II FAS enzymes 
shared with primary metabolism would handle reduction of the 3-keto group 
during each elongation cycle. In previous chapter, we have demonstrated that 
FabH and its homologue RedP, which catalyze the initial condensation in fatty 
acid and undecylprodiginine biosynthesis respectively, are highly selective for 
either straight (RedP) or branched-chain (FabH) acyl CoA substrates [59].  
Specifically RedP will only process acetyl-CoA while FabH is more efficient with 
branched acyl-CoA substrates. Additionally both enzymes have been shown to 
possess differing ACP specificities; RedP would only process the RedQ, while 
FabH was more efficient with FabC. This combination of acyl-CoA and ACP 
specificity provides for a separation of the two processes and control of the final 
product, at initiation step. 
Separate enzymes and dedicated ACPs thus appear to be key for 
separating the primary and secondary fatty acid biosynthetic process. As only 
these genes are found in the secondary metabolite gene cluster, the remaining 
enzymes to complete each cycles are thus likely to be shared. To date most work 
on this metabolic crosstalk has focused on FabD (malonyl-CoA:ACP 
transacylase) is the most well-established and widespread example of a 
crosstalk between fatty acid biosynthesis (a primary metabolic process) and 
polyketide biosynthesis (a secondary metabolic process) [60]. The gene for fabD 
is clustered with fabH, fabF and fabC [2]. Studies have revealed that FabD has 
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no significant ACP selectivity and plays an important role in both natural product 
and fatty acid biosynthetic processes.  
The genes encoding 3-ketoacyl-ACP reductase (FabG), 3-hydroxyacyl-ACP 
dehydratase (FabA), and enoyl-ACP reductase (FabI), putatively shared between 
primary and secondary fatty acid synthesis, have not been characterized in 
Streptomyces (Fig. 9). The corresponding genes are not present within the 
streptomycetes’s FAS gene cluster. Analysis of the S. coelicolor genome 
sequence has revealed the presence of one fabI gene (SCO1814, encoding an 
enoyl-ACP reductase), and three potential fabG genes (SCO1815, SCO1345, 
SCO1846, encoding β-ketoacyl-ACP reductase) [61]. The putative FabI has not 
been previously characterized and of the three possible candidates for fabG, only 
one (SCO1815, which lies immediately adjacent to fabI) has been partially 
characterized [62]. In this study the structure and functional role of SCO1815 was 
determined. The ketoreductase activity of SCO1815 was monitored by employing 
the reverse reaction i.e. oxidation of 3-hydroxyacyl-ZhuG to 3-oxoacyl-ZhuG 
(ACP from R1128, an aromatic polyketide). The activity of this enzyme has not 
been measured with the cognate ACP (FabC or RedQ), and the specificity for 
acyl group was not determined. We posited that a) the FabI (encoded by 
SCO1814) and the putative FabG (encoded by SCO1815) would have enoyl-
ACP reductase and 3-ketoacyl-ACP reductase activity respectively and b) that 
neither would show selectivity for the ACP substrate (FabC or RedQ), or the 
branching in the acyl chain. This activity would permit them to process the acyl 
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chains for both the primary and secondary metabolism and would contrast the 
initiation enzyme selectivity. We also posited that SCO1815 would have 3-
ketoacyl-ACP reductase activity as it is cluster with FabI similar to the other 
organism such as M. tuberculosis, M. smegmatis [61]. Accordingly the catalytic 
activity and substrate specificity of the FabG homologs (encoded by SCO1345 
and SCO1346) might be dramatically different if their biological role is unrelated 
to fatty acid biosynthesis.  
In the aim 2 and 3 we have characterized the three FabG and FabI homologs. 
Kinetic studies demonstrated that S. coelicolor FabI and FabG, encoded by 
SCO1814 and SCO1815, process both straight and branched acyl-chains in their 
respective substrates. In addition, both enzymes can utilize either FabC or RedQ 
as the ACP components of the substrate. These findings are consistent with 
predictions. Surprisingly 3-ketoacyl-ACP activity was also observed with the 
FabG homologs encoded by SCO1345 and SCO1346. However differences in 
cofactor specificity, overall activity and ACP selectivity were observed over that 
for the SCO1815 FabG. 
3.3 Materials and Methods  
Materials: β-NADH and β-NADPH were from Research Products 
International Corp. All other chemicals including unlabeled CoA derivatives were 
from Sigma. Cosmid 3F7 and 4A7 containing S. coelicolor genomic DNA were 
kindly provided by John Innes Institute. FabC, RedQ and AcpP (the Escherichia 
coli ACP) were sourced as described previously [46, 63, 64]. Preparation of 
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malonyl-ACPs and crotonoyl-ACPs was carried out as described previously in 
aim 1. 
S. coelicolor and E. coli fabG. The genes encoding SCO1815, SCO1345 and 
SCO1346 (fabG) were amplified from the appropriate S. coelicolor cosmids by 
PCR using the primers 5’- CATATGAGCCGCTCGGTTCTC -3’ and 5’-
GGATCCTCAGTGACCCATTCCCAGTCC-3’ (SCO1815); 5’- 
CATATGACTGAACTGCCCGAGCCCTCC -3’ and 5’ 
GGATCCTCAGGCCACGCCGGCGTTC-3’ (SCO1345) and 5’- 
CATATGTCCACCACTGAGCAGCG -3’ and 5’-
GGATCCCTAGTCGAGCGGTCCGCC-3’ (SCO1346). The E. coli fabG was 
amplified from E. coli genomic DNA by PCR using 5’- 
CATATGAATTTTGAAGGAAAAATCGCACTG -3’ and 5’- 
GGATCCTCAGACCATGTACATCCCGCCG-3’ (restriction sites underlined). The 
amplified inserts were digested with NdeI and BamHI and cloned into the pET15b 
to provide the expression plasmid for SCO1815 (pRS1), SCO1345 (pRS2) and 
SCO1346 (pRS3) and E. coli fabG (pRSE1). 
S. coelicolor and E. coli fabI.  The SCO1814 gene (encoding FabI) was 
amplified from the appropriate S. coelicolor cosmid using the forward primer 5’-
CATATGAGCGGAATTCTCGAGGGCAAG-3’ (introducing a NdeI restriction site) 
and a reverse primer 5’-GGATCCTCAGGCGCCGATGGCGTGC-3’ (introducing 
a BamHI restriction site). The E. coli fabI was amplified from E. coli genomic DNA 
using the forward primer 5’-CATATGGGTTTTCTTTCCGGTAAG-3’ (introducing a 
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NdeI restriction site) and reverse primer 5’- 
GGATCCTTATTTCAGTTCGAGTTCG-3’ (introducing a BamHI restriction site). 
The resulting PCR products were digested with NdeI and BamHI, and ligated into 
the corresponding sites in pET15b to provide the S. coelicolor fabI expression 
plasmid, pRS4 and the E. coli fabI expression plasmid, pRSE2. 
Protein expression and purification. All plasmids were used to transform E. 
coli BL21(DE3) cells. The resulting transformants were grown at 37 oC in LB 
medium containing 100 µg mL-1 ampicillin to an A600 = 0.6, induced with 0.1mM 
isopropyl-β-D-thiogalactopyranoside, and incubated for 3 h at 37 oC. Cells were 
harvested by centrifugation at 12,000 g for 10 min at 4 oC, and stored at -80 oC. 
The resulting E. coli cell pellets were suspended in lysis buffer-A (50mM 
sodium phosphate buffer pH 7.2, 300 mM NaCl, 5 mM 2-mercaptoethanol, 10% 
glycerol, 0.05% (v/v) Tween-20) with 10 mM imidazole and lysozyme (1 mg mL-
1). The resulting cell suspension was incubated on ice for 30 min and cell lysate 
was cleared by centrifugation at 16,000 g for 20 min. The crude cell extract was 
loaded onto a Ni-NTA resin column. The N-terminal polyhistidine-tagged protein 
was eluted by using buffer-A with 300 mM imidazole. Fractions containing pure 
protein were pooled, exchanged with 50mM sodium phosphate buffer pH 7.2 and 
stored in 20% glycerol at -80 oC. 
 
General procedures for synthesis of (E)-S-(2-acetamidoethyl) alk-2-
enethioate (enoyl-NAC thioester) substrates for FabI assays. Straight and 
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branched-chain enoyl-NAC compounds, ranging from C4 to C10 in the alkyl chain 
length were synthesized according to general Scheme 1. Reactions were 




Scheme 1. General scheme for synthesis of (E)-S-(2-acetamidoethyl) alk-2-
enethioate (enoyl-NAC).  
 
Synthesis of alkanal (1). Dimethyl sulfoxide (DMSO) (6.2 mL, 88 mmol) was 
added dropwise to a stirred solution of oxalyl chloride (3.80 mL, 44 mmol) in dry 
dichloromethane (CH2Cl2) (100 mL) at -78 
oC under argon atmosphere. After 30 
min a solution of the starting alcohol (3.0 g, 29 mmol) was added dropwise and 
the reaction mixture was stirred at -78 oC for 1.5 h. Triethyl amine (20.45 mL, 147 
mmol) was added dropwise and the reaction mixture was allowed to warm to 
room temperature. Saturated aqueous solution ammonium chloride (NH4Cl) 
solution (30 mL) was added and the organic layer was separated. The resulting 
aqueous phase was extracted with CH2Cl2 (3 × 40 mL), and combined organic 
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layers were dried over anhydrous sodium sulfate (Na2SO4) and concentrated in 
vacuo to give the corresponding aldehyde (1). 
Synthesis of (E)-methyl alk-2-enoate (2). Methyl diethylphosphonoacetate 
(5.86 g, 27 mmol) was added dropwise to a stirred solution of the sodium hydride 
(0.66 g, 27 mmol) in 1.2-dimethoxyethane (15 mL) at 0 oC under argon 
atmosphere and stirred for 30 min. After dropwise addition of the aldehyde (1) 
(2.0 g, 23 mmol), reaction mixture was allowed to warm to room temperature and 
stirred for 3h. The reaction mixture was quenched with cold water and extracted 
with ethyl acetate (EtOAc) (3 × 15 mL). The combined organic layers were 
washed with brine (20 mL), dried over Na2SO4 and concentrated in vacuo. The 
crude product was purified by column chromatography (EtOAc : hexane, 7:93) to 
yield the desired ester (2). 
Synthesis of (E)-alk-2-enoic acid (3).  To a stirred solution of ester (2) (2.0 g, 
14 mmol) in tetrahydrofuran (THF):water (H2O)  (40mL 1:1) was added lithium 
hydroxide (LiOH) (1.0 g, 42.2 mmol), and the mixture was heated at reflux. After 
2.5 h the reaction mixture was cooled down to 0 oC, and acidified with 1N 
hydrochloric acid (HCl). The layers were separated and the aqueous phase 
extracted with EtOAc (3 × 30 mL). The combined organic layers washed with 
brine, dried over sodium sulfate and concentrated in vacuo to give the 
corresponding carboxylic acid (3).  
Synthesis of (E)-S-(2-acetamidoethyl) alk-2-enethioate (4). To a stirred 
solution of the carboxylic acid (3) (1.0 g, 7.81 mmol) in anhydrous CH2Cl2 (20 
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mL) at 0 oC, under nitrogen atmosphere, was added N-acetyl cysteamine (0.94 
mL, 8.98 mmol) followed by 4-(N,N-dimethylamino)pyridine (DMAP) (0.24 mg, 
1.95 mmol), and N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride 
(EDCl) (1.5 g, 7.81 mmol). The reaction mixture was allowed to warm to room 
temperature and stirred for overnight. The reaction was quenched with saturated 
aqueous NH4Cl (15 mL) and extracted with CH2Cl2 (3 × 20 mL). The combined 
organic layers were dried over sodium sulfate, concentrated in vacuo and the 
residue was purified by column chromatography (hexane/EtOAc 40:60) to yield 
the desired product 4. 
General procedures for synthesis of S-(2-acetamidoethyl) 3-
oxoalkanethioate (3-ketoacyl-NAC thioester) substrates for FabG assays. 
Straight and branched 3-keto acyl-NAC compounds with alkyl chain length 
ranging from C4 to C10 were synthesized according to general Scheme 2.  
 
Scheme 2. General scheme for synthesis of S-(2-acetamidoethyl) 3-
oxoalkanethioate (3-ketoacyl-NAC). 
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Reactions were monitored by TLC and all compounds were characterized by 1H 
NMR spectroscopy. 
 
Synthesis of methyl 3-oxoalkanoate (5). Methyl acetate (7.50 mL, 93.8 mmol) 
was added to a stirred solution of lithium diisopropylamide (LDA) (39.0 mL of 1.8 
M solution in THF, 70.3 mmol) in THF (100 mL) at -78 oC. After stirring for 15 
min, a solution of the starting acyl chloride in THF was added dropwise and the 
reaction mixture was stirred at 78 oC for 1 h before being warmed to room 
temperature and stirred for 3.0 h. The reaction mixture was quenched with 1N 
HCl and extracted with EtOAc (3 × 100 mL). The combined organic extract were 
washed with brine, dried over Na2SO4 and concentrated in vacuo. The crude 
product was purified by column chromatography (hexane: EtOAc, 95:5) to afford 
the desired ester (5). 
Synthesis of methyl 3-hydroxyalkanoate (6). Sodium borohydride (NaBH4) 
(1.90 g, 50 mmol) was added slowly to a stirred solution of 5 (3.0 g, 50 mmol) in 
anhydrous methanol (20 mL) at 0 oC, and the reaction mixture was stirred at 0 oC 
for 20 min. The resulting solution was quenched with 1N HCl and extracted with 
EtOAc (3 × 20 mL). The combined organic layers were dried over Na2SO4, 
concentrated in vacuo and purified with column to give corresponding methyl 3-
hydroxyalkanoate (6). 
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Synthesis of S-(2-acetamidoethyl) 3-hydroxyalkanoate (8). Hydrolysis of 6 to 
provide 7 and subsequent conversion to 8 was analogous to the steps for 
formation of formation of enoyl NAC (described above).  
Synthesis of S-(2-acetamidoethyl) 3-oxoalkanethioate (9). A suspension of 
pyridinium chlorochromate (1.44 g, 6.72 mmol) in anhydrous CH2Cl2 (50 mL) was 
treated with 8 (1.0 g, 4.48 mmol). The mixture was stirred at room temperature 
for 2 h. Diethyl ether (Et2O) (100 mL) was added to precipitate the chromium 
salts. After filtration through silica gel pad the solvent was evaporated to yield 
crude keto compound, which was purified by column chromatography (hexane/ 
EtOAc 50:50) to afford the desired compound 9. 
FabG and FabI assays. Spectrophotometric assays were used to assess 
substrate specificity of FabG and FabI. FabG activity was determined by 
monitoring the conversion of the 3-ketoacyl-NAC substrate to 3-hydroxyacyl-
NAC. The conversion of the enoyl-NAC substrate to acyl-NAC was monitored to 
determine the activity of FabI. Assays were performed in the presence of 50 mM 
sodium phosphate buffer (pH 7.2), 0.4 mM of NADH (or NADPH), 1.0 mM 
substrate (suspended in DMSO to give a final concentration of 1%) and 0.05 μg 
of protein in a final volume of 100 μL. The reaction mixture was incubated at 
room temperature for 10 min and enzymatic activity was measured by monitoring 
the decrease in absorbance at 340 nm due to the consumption of NADH (or 
NADPH). Steady-state kinetic measurements were obtained by determination of 
FabG or FabI activity using variable concentrations (0.125 -16.0 mM) of either 3-
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ketoacyl-NAC or enoyl-NAC and constant concentration (400 µM) of either 
NADPH or NADH respectively. All reactions were performed at least in triplicate 
and nonlinear regression analysis with Grafit version 4.012 (Erithacus Software, 
Horley, United Kingdom) was used to determine kcat and KM values. 
FabG and FabI activities were also determined with 3-ketoacyl-ACP and 
enoyl-ACP respectively by using LC-MS based assay under the similar reaction 
condition as described above. Briefly, FabI was incubated with either crotonoyl-
AcpP (the E.coli fatty acid synthase ACP), or crotonoyl-RedQ, and NADH in a 
final volume of 20 μL for 10 min. Coupled assays were carried out to obtain the 
FabG activity. First FabH (or RedP) was incubated with butyryl-CoA (or 
isobutyryl-CoA) with malonyl-FabC (or malonyl-RedQ) in a similar way as 
described before in aim 1 in 50 mM sodium phosphate buffer (pH 7.2), in a total 
volume of 20 μL. The reaction mixture was incubated at 25 ⁰C for 10 min (leading 
to generation of the 3-ketoacyl ACP) and then treated with FabG and either 
NADPH or NADH for 10 min. All reactions were quenched with 20 μL of 10% 
formic acid and products were analyzed using LC-ESI-MS performed with a high 
resolution mass spectrometer externally mass calibrated prior to analysis to 
obtain mass accuracy within ±5 ppm. Chromatography was performed with an 
Accela HPLC system (Thermo Fisher Scientific, Waltham, MA) using a Discovery 
(3µm, 15cm × 2.1mm, Supelco) reverse phase column at a flow rate of 200 
µL/min. Solvent A was water with 0.05% formic and Solvent B was acetonitrile 
with 0.5% formic acid. The solvent gradient initiated with Solvent A (99%) for 5 
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min and then went to 99% of Solvent B over 25 min. A final 2 min at 99% Solvent 
B was used before re-equilibrated with solvent A. The HPLC eluent was directed 
to a ThermoElectron LTQ-Orbitrap XL Discovery instrument (San Jose, CA, 
USA), equipped with an ESI ion max source. The ionization interface was 
operated in the positive mode using the following settings: source voltage, 4 kV; 
sheath and aux gas flow rates, 50 and 10 units respectively; tube lens voltage, 
100 V; capillary voltage, 14 V; and capillary temperature, 300°C. LTQ with 
collision induced dissociation (CID) values of 30 was used for LC-ESI-MS/MS 
experiments. 
3.4 Results and Discussion 
β-Ketoacyl-ACP reductase (FabG). The analysis of the S. coelicolor genome 
sequence has revealed the presence of three likely fabG gene (SCO1815, 
SCO1345, SCO1346, encoding β-ketoacyl-ACP reductase). To probe the 
physiological role of these three S. coelicolor fabG homologs, the genes were 
expressed in E. coli, and the corresponding recombinant proteins were purified 
as a soluble N-terminal His6-tag protein. S. coelicolor produces predominantly 
branched-chain fatty acids, whereas E. coli produces only straight chain fatty 
acids. In order to facilitate a comparison of S. coelicolor ketoacyl-ACP reductase 
acyl specificity with that of a straight-chain fatty acid producer, the E. coli fabG 
gene was also expressed and purified. Analysis of affinity purified proteins by 
SDS-PAGE showed a major band with an apparent molecular weight of 
approximately 28 kDa consistent with the expected molecular weight (Fig. 10).  
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On the basis of earlier study which demonstrated that FabH (β-Ketoacyl-
ACP synthase III) from E. coli is specific for acetyl-CoA [12] we hypothesized that 
E. coli FabG would be specific for the straight-chain substrates. Despite the 
important role of FabG in FAS, analysis of specificity for straight and branched-
chain substrates has not been investigated. Thus, a range of straight and 
branched-chain carboxylic acids were synthesized and activated as either a NAC 
or ACP derivative and were tested with the three S. coelicolor FabG homologs 
and the E. coli FabG. 
 
Figure 10. SDS-PAGE of purified S. coelicolor FabG’s (SCO1815, SCO1346, 
SCO1345), and E. coli FabG. 
M-Standard protein marker; FL-Flow through; W-Wash; E-Protein elution fraction. 
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β-Ketoacyl-NAC Specificity. The activity of FabG’s with a series of straight and 
branched-chain β-ketoacyl-NAC substrates was determined using a NADPH-
based spectrophotometric assay. The apparent KM for all NAC substrates were 
over 2 mM (the high apparent KM can be attributed to using NAC thioesters in 
place of the natural ACP substrate), and limiting substrate solubility prevented 
determination of Vmax and calculating of kcat with these substrate mimics. Limiting 
solubility also prevented assays with substrate mimics with chain lengths greater 
than C10. Therefore, the catalytic efficiency (kcat/KM) was determined under 
substrate-limited conditions. Kinetic analysis revealed that all three FabG 
homologs are capable of utilizing both straight and branched-chain substrates 
(Table 2).  
For the streptomycetes FabG homologs this result is consistent with a 
FabGs role in fatty acid and prodiginine biosynthesis, wherein it processes 
branched-chain products of FabH for primary metabolism, as well as, straight-
chain products of RedP for undecylprodiginine biosynthesis. Furthermore, all 
FabGs were also observed to process β-ketoacyl-NAC substrates with a range of 
alkyl chain lengths C6–C10, and catalytic efficiency generally increased as 
substrate chain length increased. This general trend was observed for all FabGs 
with branched-chain substrates. In the case of the straight-chain substrates the 
greatest activity was observed with the C8 substrates. The higher catalytic 
efficiency with longer chain substrates corresponds to the average chain length 
of the substrates that are processed in a fatty acid by FabG and potentially reflect 
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greater occupancy of the appropriate acyl binding pocket in the overall catalytic 
process. 
































    
3-Ketohexanoic-NAC 38 ± 1.5 16 ± 1.2 160 ± 1.0 280 ± 17.0 
3-Ketooctanoic-NAC 93 ± 9.0 118 ± 6.0 205 ± 7.0 1912 ± 133.0 
3-Ketodecanoic-NAC 75 ± 3.0 46 ± 1.0 92 ± 5.0 1375 ± 32.0 
Branched-chain  
    
5-Methyl-3-ketohexanoic-
NAC 
11 ± 1.1 91 ± 8.0 15 ± 3.0 36 ± 4.0 
6-Methyl-3-ketoheptanoic-
NAC 
92 ± 5.0 123 ± 6.0 292 ± 5.0 703 ± 14.0 
7-Methyl-3-ketooctanoic-
NAC 
122 ± 2.0 385± 48.0 350 ± 47.0 1293 ± 20.0 
 
The FabG from E. coli, showed a several fold higher apparent efficiency 
than the S. coelicolor FabGs. This difference of catalytic activity could be innate 
or a result of assay conditions with substrate mimics. Finally the data 
demonstrates for the first time that the FabG from E. coli can utilize both straight 
and branched-chain β-ketoacyl substrates, with comparable efficiency. This 
observation is in contrast to the data with the E. coli FabH, which has been 
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shown to have a strong preference for straight-chain substrates such as acetyl 
and propionyl-CoA [57]. While E. coli does not generate branched-chain fatty 
acids, production of small levels of them has been observed when the natural 
FabH is replaced with FabH which can process branched acyl-CoA starter units 
[58, 65]. This production presumably is dependent upon the relaxed acyl group 




Figure 11. Comparison of S. coelicolor FabG’s (SCO1815, SCO1346, 
SCO1345), and E. coli FabG activities with NADPH and NADH. 
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The cofactor preference of all the enzymes was also determined using 
both NADPH and NADH. SCO1815, SCO1345 and E.coli FabG all demonstrated 
at least 10-fold higher catalytic activity with NADPH than NADH, consistent with 
previous studies of FabG proteins [66-68]. In contrast SCO1346 was highly 
specific for NADH and in this case the catalytic activity was at least 100-fold 
higher than with NADPH (Fig.11). 
ACP Specificity. Since the acyl-NAC is a poor mimic of the natural substrate for 
FabG, their activity with acyl-ACPs was also determined, using an LC/MS assay. 
The S. coelicolor SCO1815 was initially assayed by employing the reverse 
reaction i.e. oxidation of 3-hydroxyacyl-ZhuG to 3-oxoacyl-ZhuG (ZhuG is the 
ACP used in the biosynthesis of the polyketide R1128, a nonnative pathway 
which has been introduced into S. coelicolor). This approach was taken to avoid 
problems associated with 3-ketoacyl-ACP preparation and stability [62]. Studies 
have shown that the acyl group specificity of an enzyme can change when using 
nonnative ACPs [69]. Our approach was a) to generate the 3-ketoacyl-ACP 
enzymatically and then use it immediately to assay the reaction in the forward 
direction, and b) to test the S. coelicolor FabG homologs with the physiologically 
relevant acyl-ACPs (RedQ and FabC). The phosphopantetheine ejection assay 
was carried out to monitor the reaction with a previously described method [70]. 
While a detailed kinetic analysis was not possible because of limitations of acyl-
ACP substrate production, a broad assessment of acyl and ACP specificity was 
possible for the all the FabG proteins.  
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Initially, FabH was incubated with butyryl-CoA and malonyl-FabC to 
generate the straight-chain β-ketoacyl-FabC and the product was analyzed with 
LC/MS (Fig. 12A).  
 
 
Figure 12. Coupled assay of FabH and FabG. Left panel, A) LC/MS extracted 
ion chromatogram of the FabH reaction with Butyryl-CoA and malonyl-FabC. B) 
Total ion chromatogram, m/z of 952 corresponds to the major mass-charge ratio 
observed for ACP-bound 3-keto condensed product of FabH reaction. The MS2 
spectra of 952 (373 corresponds to a phosphopantetheine thioester of expected 
3-keto condensed product of FabH) (C), and of the hydroxy product with 
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SCO1815 (D), SCO1345 (E) and SCO1346 (F). In comparison to SCO1815 and 
SCO1346, a 10-fold higher concentration of SCO1345 was necessary to obtain 
the complete conversion of 3-ketoacyl substrate to 3-hydroxyacyl product. 
Similarly, Right Panel, G) LC/MS MS extracted ion chromatogram of the FabH 
reaction with Isobutyryl-CoA and malonyl-FabC, H) Total ion chromatogram of 
the FabH reaction product, I) The MS2 spectra of 952. The phosphopentatheine 
fragment of hydroxy product of SCO1815 (J), SCO1345 (K) and SCO1346 (L). 
 
A major m/z 952 was observed corresponding to the major mass-charge 
ratio for the condensed ACP bound product of FabH reaction (Fig. 12B). A MS2 
of m/z 952 produced a major m/z 373 signal, consistent with the mass of 
phosphopantetheine thioester of the expected 3-keto condensed product of FabH 
(Fig. 12C). After addition of NADPH (or NADH) and all three FabGs to the β-
ketoacyl-FabC product of FabH, the same analysis provided a major m/z 375 (an 
increase in 2 atomic mass units) which is consistent with the expected mass of 
the β-hydroxyacyl-FabC product (Fig. 12D, E and F for SCO1815, SCO1345 and 
SCO1346 respectively). The level of reduction using SCO1345 could only be 
achieved under the same assay conditions by using 10-fold higher levels of the 
enzyme. This level of difference in catalytic efficiency was not observed when the 
acyl-NAC substrate mimics were used. 
Assays were also carried out with branched-chain 3-ketoacyl-FabC. These 
were generated using isobutyryl-CoA (in place of butyryl-CoA) and malonyl-FabC 
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with FabH (Fig. 12G, H and I). These assays revealed conversion of the 3-
ketoacyl-FabC with all three FabG homologs (Fig. 12J, K, and L). The lower 
catalytic efficiency for SCO1345 was observed with both the straight and 
branched-chain 3-ketoacyl-FabC substrates. The ability to process both straight 
and branched acyl-ACP substrates and the cofactor specificity of the FabG 
homologs is consistent with the observations using 3-ketoacyl- NAC substrate 
mimics. 
Additionally, activity of each FabG was assayed with the 3-ketoacyl-ACP 
substrates using both the FAS ACP (FabC) and the prodiginine ACP (RedQ) 
(Fig. 13). The expectation was that both ACP substrates would be used if the 
FabG is involved in both processes. These assays were carried out in an 
analogous fashion to that used to look at straight and branched-chain specificity. 
The phosphopantetheine fragment of the starting substrate malonyl-FabC 
exhibited expected mass of 347 (Fig. 13A). The β-ketoacyl-chain substrates were 
generated by using butyryl-CoA and malonyl-FabC with FabH (Fig. 13B), and 
after addition of FabG, the expected reduced product was observed (Fig. 13C, D, 
E and F for SCO1815, SCO1345 SCO1346 and E.coli FabG respectively). 
Similarly, the β-ketoacyl-RedQ substrate was generated by the reaction of 
RedP with butyryl-CoA and malonyl-RedQ and was analyzed by LC/MS. The 
expected phosphopantetheine fragment of the starting substrate malonyl-RedQ 
was exhibited in the LC/MS assay (Fig. 13G). 
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Similar to the FabH product, a condensed product (β-ketoacyl-RedQ) of 
RedP was observed after incubation with malonyl-RedQ and butyryl-CoA (Fig. 
13H). Again a reduced product was obtained after addition of FabG (Fig. 13I, K 
and L, SCO1815, SCO1346 and E.coli FabG). In contrast SCO1345 was not 
active with the RedQ substrates (Fig. 13J).  
 
 
Figure 13. Coupled assay of FabH and FabG, with butyryl-CoA and malonyl-
FabC (or malonyl-RedQ). Left panel, Phosphopantetheine fragment of, starting 
substrate malonyl-FabC (A), 3-keto product of FabH reaction with butyryl-CoA 
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and malonyl-FabC (B), reduced product of SCO1815 (C), SCO1345 (D), 
SCO1346 (E) and E.coli FabG (F). 
Similarly, Right panel, Phosphopantetheine fragment of, malonyl-RedQ (G), 3-
keto product of FabH reaction with butyryl-CoA and malonyl-RedQ (H), reduced 
product of SCO1815 (I), SCO1346 (K), and E.coli FabG (L), no product was 
observed with SCO1345 (J). 
These data demonstrate that out of three S. coelicolor FabGs enzymes, 
SCO1815 and SCO1346 have capability to process the ACPs from both fatty 
acid and undecylprodiginine biosynthesis. This is consistent with one or both of 
these FabGs processing 3-ketoacyl-FabC substrates for primary metabolism, 
and 3-ketoacyl-RedQ substrates for secondary metabolism. The ability of the E. 
coli FabG to process 3-ketoacyl-RedQ (Fig. 13L) demonstrates that this enzyme 
can tolerate changes in both the acyl and ACP components of the 3-ketacyl-ACP 
substrate. 
These analyses are consistent with the predications for the activity and likely 
role of the FabG encoded by SCO1815. Notably it uses both straight and 
branched-chain 3-keotacyl-ACP substrates, using either FabC or RedQ. These 
observations in addition to the NADPH cofactor specificity and colocation of the 
gene with SCO1814 (and detailed below this has the enoyl-ACP reductase 
activity required for fatty acid biosynthesis) all support the hypothesis this is the 
primary FabG used for both fatty acid and undecylprodiginine biosynthesis. 
Colocation of genes for the FabG and FabI are also observed in other organisms, 
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notably mycobacterium [61]. Given all of this and the literature which to date 
supports the role of a single FabG in a type II dissociated fatty acid biosynthetic 
process [61], we were surprised to see 3-ketoacyl-NAC and 3-ketoacyl-ACP 
activity with FabG encoded by SCO1345 and SCO1346. The markedly lower 
activity of the FabG encoded by SCO1345 (compared to the other two FabG 
homologs) when 3-ketoacyl-ACP substrates were used indicates that these are 
not the physiological substrates and this reductase is involved in another cellular 
process. The same cannot be said for the FabG encoded by SCO1346, which 
differs from the SCO1815 encoded FabG by cofactor specificity. The 
physiological role of both of these FabG homologs thus remains elusive. 
Enoyl-ACP reductase (FabI). The analysis of the S. coelicolor genome 
sequence has revealed the presence of one fabI (SCO1814). In order to test the 
hypothesis that SCO1814 encodes the enoyl-ACP reductase used in fatty acid 
and undecylprodiginine biosynthesis, the fabI (SCO1814) was amplified from S. 
coelicolor genomic DNA, expressed in E. coli, and purified. The purified protein 
had the expected molecular mass of approximately 30 kDa as determined by 
SDS-PAGE. In addition to SCO1814, the previously characterized E. coli fabI 
gene [71, 72] was also expressed and purified (also with the expected molecular 
mass of approximately 30 kDa) (Fig. 14).  
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Figure 14. SDS-PAGE of purified S. coelicolor InhA (A) and E. coli FabI (B). 
M-Standard protein marker; FL-Flow through; W-Wash; E-Protein elution fraction. 
 
Since E. coli generates only straight-chain fatty acids we hypothesized that FabI 
from E. coli would have a strong preference for straight-chain substrates (as in 
the case of E. coli FabH). To date no data has compared the FabI activity with 
straight and branched-chain substrates. Therefore it would be useful to compare 
this FabI acyl specificity with that of the S. coelicolor FabI. In this study, a series 
of straight and branched-chain substrates varying in the chain length were 
synthesized (Scheme 1) and used in the spectrophotometric and LC/MS assay. 
Enoyl-NAC Specificity. The activity of FabI with a series of straight and 
branched-chain enoyl-NAC substrates (C4–C10) was determined using an NADH-
dependent spectrophotometric assay. The apparent KM for all enoyl-NAC 
substrates was over 2 mM. Substrate solubility prevented the use of longer 
substrate (more than C10) and concentration well above the KM. Therefore, the 
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apparent catalytic efficiency (kcat/KM) values were obtained under substrate-
limited conditions as in the case of FabG. The high KM likely reflects the use of 
NAC thioesters in place of ACPs. Nonetheless, these kinetic analyses 
demonstrated that S. coelicolor FabI has the capability of utilizing all of the 
straight and branched-chain enoyl-NAC substrates tested (C4-C10) (Table 2). No 
clear pattern was observed between catalytic efficiencies using straight and 
branched enoyl-NAC substrates of comparable chain length. These observations 
are consistent with the predicted activity of the FabI and its role in both fatty acid 
and prodiginine biosynthesis (Fig. 9), wherein it processes both short and long 
chain products of FabH (or RedP) or FabF (or RedR) respectively. The catalytic 
efficiency of FabI with various straight-chain enoyl-NAC (C4 to C10 chain length) 
generally increased as substrate chain length increased and general trend was: 
2-octenoyl-NAC > 2-decenoic-NAC > 2-hexenoic-NAC > 2-butenoic-NAC. A 
similar trend was also observed with the branched-chain substrates. The 
preference for processing longer straight-chain enoyl-substrates has previously 
been observed and is again likely the result of greater occupancy on the enoyl-
group binding pocket of the enzyme [73, 74]. Similar observations of processing 
both straight and branched-chain enoyl-NAC substrates were seen with the E. 
coli FabI (Table 3). 
Thus in both organisms that produce branched-chain fatty acids and those 
which produce only straight-chain fatty acid the reductive enzymes FabI and 
FabG can process both straight and branched-chain substrates. The apparent 
 58 
catalytic efficiency of the E coli FabI was a several folds higher than the S. 
coelicolor FabI, an observation made previously when the E. coli FabI was 
compared with FabI from other enzymes [75]. 
 


















2-Butenoic-NAC 10 ± 1.9 97 ± 6.0 
2-Hexenoic-NAC 19 ±1.0 231 ± 12.0 
2-Octenoic-NAC 
2-Decenoic-NAC 
49 ± 1.0 
20 ± 1.2 
611 ± 15.0 
157 ± 27.0 
Branched-chain 
  
4-Methyl-2-pentenoic-NAC 17 ± 1.5 12 ± 2.0 
5-Methyl-2-hexenoic-NAC 2 ± 0.1 0.37 ± 0.05 
6-Methyl-2-heptenoic-NAC 29 ± 2.0 302 ± 6.0 
7-Methyl-2-octenoic-NAC 63 ± 4.0 361 ± 19.0 
9-Methyl-2-decenoic-NAC 9.0 ± 1.0 10 ± 1.0 
 
It has also been observed that enoyl-reductase (FabI) from other 
organisms prefer CoA over NAC thioesters (even though CoA is not the 
physiological substrate) and that NADH is the preferred cofactor [75]. Similar 
preferences were observed with the S. coelicolor FabI in this study, and in fact no 
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activity was observed with NADPH even when enzyme concentration was 




Figure 15. Comparison of S. coelicolor InhA (A) and E. coli FabI (B).activities 
with NADPH and NADH. 
 
ACP Specificity. Similar to FabG, an LC/MS assay was carried out to determine 
the FabI specificity with the ACPs from both metabolic processes (Fig. 16). In this 
study an AcpP from E.coli fatty acid synthase was used because of technical 
difficulties in generating a sufficient amount of apo-FabC. Crotonoyl-AcpP was 
generated from apo-AcpP (the E. coli fatty acid synthase ACP) and crotonoyl-
CoA, using Sfp (a phosphopantetheinyl transferase) and analyzed by LC/MS 
(Fig. 16A).  
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Figure 16. LC/MS analysis of FabI reaction with crotonoyl-AcpP (or crotonoyl-
RedQ) and NADH. Left panel A) mass spectrum of the starting substrate 
crotonoyl-AcpP B) Total ion chromatogram, m/z C) The MS2 spectra of 1115 (329 
corresponds to a phosphopantetheine thioester of.crotonoyl group) D) Saturated 
product of FabI with crotonoyl-AcpP and NADH 
Right panel E) mass spectrum of the crotonoyl-RedQ F) m/z G) The MS2 spectra 
of 1016 H) Saturated product of InhA  
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An m/z 1115 was observed corresponding to the mass-charge ratio observed for 
crotonoyl-AcpP (Fig. 16B). An MS2 of the parent m/z 1115 provides a fragment 
m/z 329, which is consistent with the expected mass of phosphopantetheine 
thioester of crotonoyl group (Fig. 16C).  
The FabI catalyzed the reduction of crotonoyl-AcpP by NADH to the 
saturated product, (butyryl-AcpP) with a predicted mass 331 was observed (Fig. 
16D). Similarly, crotonoyl-RedQ was generated to evaluate the role of FabI in 
secondary metabolism, by the incubation of Sfp with apo-RedQ and crotonoyl-
CoA (Fig.16E, F and G). Consistent with FabI’s role in secondary metabolism; it 
was able to process the crotonoyl-RedQ into the saturated product (Fig. 16H). 
These assays clearly demonstrate that SCO1814 (FabI) has both enoyl-
NAC and enoyl-ACP reductase activity. In both cases FabI utilizes various chain 
lengths of straight and branched-chain substrates. Furthermore, FabI does not 
discriminate between ACPs from primary metabolism and secondary 
metabolism. A gene encoding the enoyl-ACP reductase (FabI) is not present in 
the red biosynthetic gene cluster and thus all evidence support a role of 
SCO1814 in both fatty acid and undecylprodiginine biosynthetic process in S. 
coelicolor (Fig. 9). 
In this study we have cloned all three 3-ketoacyl-ACP reductases 
homologues (SCO1815, SCO1345, and SCO1346), along with the SCO1814 
enoyl-ACP reductase homologue from S. coelicolor and purified all proteins. We 
have carried out the first kinetic analyses of these streptomycetes enzymes and 
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demonstrated that all three FabGs homologues have 3-ketoacyl-ACP reductases 
activity, and the FabI homologue has enoyl-ACP reductase activity. The activities 
of the SCO1815 encoded FabG and the SCO1814 FabI provide compelling 
support for a role of these enzymes in providing both fatty acids for primary 
metabolism and dodecanoic acid for undecylprodiginine biosynthesis. Thus data 
now provides experimental evidence to support the role of FabG and FabI, in 
addition to FabD, in both processes and suggests they may exert no control over 
the products. In contrast the condensing enzymes (FabH and RedP) are the key 















3.5 NMR spectral data of the intermediates and final compounds  
All (E)-S-(2-acetamidoethyl) alk-2-enethioate (enoyl-NAC) compounds were 
synthesized according to the general procedures as shown in Scheme1. 
NMR spectral data of the intermediates for one representative compound. 
7-Methyloctan-1-ol: 
 
1H NMR (CDCl3, 400MHz)  3.65 (t, J =6.6 Hz, 2H), 1.60-1.51 (m, 3H), 1.37-1.28 
(m, 6H), 1.18-1.16 (m, 2H), 0.91 (d, J = 6.6 Hz, 6H). 
7-Methyloctanal: 
 
1H NMR (CDCl3, 400MHz)  9.78 (t, J =1.8 Hz, 1H).2.45-2.41 (m, 2H), 1.67-1.63 





1H NMR (CDCl3, 400MHz)  7.0-6.97 (m, 1H), 5.83 (dd, J = 1.5, 15.6 Hz, 1H), 
3.74 (s, 3H), 2.22-2.18 (m, 2H), 1.54-1.45 (m, 3H), 1.32-1.28 (m, 4H), 1.19-1.16 
(m, 2H), 0.87 (d, J = 6.6 Hz, 6H). 
(E)-9-methyldec-2-enoic acid: 
 
1H NMR (CDCl3, 400MHz)  7.12-7.08 (m, 1H), 5.83 (dd, J = 1.5, 15.6 Hz, 1H), 
2.25-2.23 (m, 2H), 1.54-1.46 (m, 3H), 1.32-1.28 (m, 4H), 1.19-1.16 (m, 2H), 0.87 
(d, J = 6.6 Hz, 6H). 
S-(2-acetamidoethyl) (E)-9-methyldec-2-enethioate: 
 
1H NMR (CDCl3, 400MHz)  6.95-6.91 (m, 1H), 6.14 (dd, J = 6.6, 15.5 Hz 1H), 
5.96 (br s, 1H), 3.48 (q, J = 6.2 Hz, 2H), 3.11 (t J = 6.4 Hz, 2H), 2.25-2.19 (m, 2H), 
1.98 (s, 3H), 1.54-1.46 (m, 3H), 1.32-1.27 (m, 4H), 1.20-1.16 (m, 2H), 0.88 (d, J 
=6.6 Hz, 6H). 





1H NMR (CDCl3, 400MHz)  6.94-6.92 (m, 1H), 6.17 (dd, J = 1.6, 15.6 Hz, 1H), 
5.98 (br s, 1H), 3.47 (q, J =6.2 Hz, 2H), 3.10 (t, J =6.2 Hz, 2H), 1.97 (s, 3H), 1.91 
(dd, J = 1.6, 6.8 Hz, 3H). 
S-(2-acetamidoethyl) (E)-hex-2-enethioate: 
 
1H NMR (CDCl3, 400MHz)  6.98-6.91 ((m, 1H), 6.15 (dd, J = 1.5, 15.5 Hz, 1H), 
5.94 (br s, 1H), 3.48 (q, J =6.5 Hz, 2H), 3.11 (t, J =6.6 Hz, 2H), 2.24-2.18 (m, 2H), 
1.98 (s, 3H), 1.55-1.49 (m, 2H), 0.96 (t, J =7.3 Hz, 3H). 
S-(2-acetamidoethyl) (E)-oct-2-enethioate: 
 
1H NMR (CDCl3, 400MHz)  6.99-6.91 ((m, 1H), 6.14 (dd, J = 1.5, 15.5 Hz 1H), 
5.93 (br s, 1H), 3.48 (q, J =6.4 Hz, 2H), 3.11 (t, J =6.5 Hz, 2H), 2.25-2.19 (m, 2H), 




1H NMR (CDCl3, 400MHz)  6.99-6.91 ((m, 1H), 6.14 (dd, J = 1.5, 15.5 Hz 1H), 
5.92 (br s, 1H), 3.48 (q, J =6.4 Hz, 2H), 3.11 (t, J =6.5 Hz, 2H), 2.25-2.19 (m, 2H), 
1.98 (s, 3H), 1.50-1.47 (m, 2H), 1.32-1.29 (m, 8H), 0.91 (t, J =6.7 Hz, 3H). 
S-(2-acetamidoethyl) (E)-4-methylpent-2-enethioate: 
 
1H NMR (CDCl3, 400MHz)  6.92 (dd, J = 6.6, 15.6 Hz 1H), 6.10 (dd, J = 1.4, 15.6 
Hz 1H), 5.91 (br s, 1H), 3.48 (q, J = 6.5 Hz,, 2H), 3.11 (t, J =6.6 Hz, 2H), 2.50-2.48 
(m, 1H), 1.98 (s, 3H), 1.10 (d, J =6.8 Hz, 6H). 
S-(2-acetamidoethyl) (E)-5-methylhex-2-enethioate: 
 
1H NMR (CDCl3, 400MHz)  6.95-6.88 (m, 1H), 6.13 (dd, J = 1.4, 15.4 Hz 1H), 
5.99 (br s, 1H), 3.47 (q, J = 6.4 Hz, 2H), 3.10 (t, J = 6.6 Hz, 2H), 2.12-2.08 (m, 




1H NMR (CDCl3, 400MHz)  6.96-6.90 (m, 1H), 6.13 (dd, J = 1.5, 15.5 Hz 1H), 
6.04 (br s, 1H), 3.46 (q, J = 6.1 Hz, 2H), 3.10 (t, J = 6.5 Hz, 2H), 2.25-2.19 (m, 
2H), 1.97 (s, 3H), 1.60-1.56 (m, 1H), 1.38-1.33 (m, 2H), 0.91 (d, J =6.6 Hz, 6H). 
S-(2-acetamidoethyl) (E)-7-methyloct-2-enethioate: 
 
1H NMR (CDCl3, 400MHz)  6.95-6.89 (m, 1H), 6.13 (dd, J = 1.5, 15.5 Hz 1H), 
6.07 (br s, 1H), 3.46 (q, J = 6.32 Hz, 2H), 3.10 (t, J = 6.6 Hz,, 2H), 2.21-2.16 (m, 
2H), 1.97 (s, 3H), 1.56-1.53 (m, 1H), 1.48-1.45 (m, 2H), 1.22-1.21 (m, 2H), 0.88 
(d, J =6.6 Hz, 6H). 
S-(2-acetamidoethyl) (E)-9-methyldec-2-enethioate: 
 
1H NMR (CDCl3, 400MHz)  6.95-6.91 (m, 1H), 6.14 (dd, J = 6.6, 15.5 Hz 1H), 
5.96 (br s, 1H), 3.48 (q, J = 6.2 Hz, 2H), 3.11 (t J = 6.4 Hz, 2H), 2.25-2.19 (m, 2H), 
1.98 (s, 3H), 1.54-1.46 (m, 3H), 1.32-1.27 (m, 4H), 1.20-1.16 (m, 2H), 0.88 (d, J 
=6.6 Hz, 6H). 
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All S-(2-acetamidoethyl) 3-oxoalkanethioate (3-ketoacyl-NAC) compounds were 
synthesized according to the general procedures as shown in Scheme2. 
NMR spectral data of the intermediates for one representative compound. 
5-Methylhexanoyl chloride: 
 
1H NMR (CDCl3, 400MHz)  2.88 (t, J = 7.3 Hz, 2H), 1.77-1.69 (m, 2H), 1.60-1.56 
(m, 1H), 1.28-1.22 (m, 2H), 0.91 (d, J =6.6 Hz, 6H). 
Methyl 7-methyl-3-oxooctanoate: 
 
1H NMR (CDCl3, 400MHz)  3.74 (s, 3H), 3.46 (s, 2H), 2.52 (t, J = 7.3 Hz, 2H), 
1.64-1.53 (m, 3H), 1.21-1.15 (m, 2H), 0.90 (d, J =6.6 Hz, 6H). 
Methyl 3-hydroxy-7-methyloctanoate: 
 
1H NMR (CDCl3, 400MHz)  4.03 (m, 1H), 3.72 (s, 3H), 2.55-2.43 (m, 2H), 1.56-




1H NMR (CDCl3, 400MHz)  4.05 (m, 1H), 2.60-2.44 (m, 2H), 1.59-1.18 (m, 7H), 
0.91-.89 (m, 6H). 
S-(2-acetamidoethyl) 3-hydroxy-7-methyloctanethioate: 
 
1H NMR (CDCl3, 400MHz)  6.10 (br s, 1H), 4.13-4.11 (m, 1H), 3.46-3.43 (m, 2H), 




1H NMR (CDCl3, 400MHz)  5.98 (br s, 1H), 3.71 (s, 2H), 3.49-3.45 (m, 2H), 3.12-
3.09 (m, 2H), 2.52 (t, J = 7.3 Hz, 2H), 1.99 (s, 3H), 1.62-1.53 (m, 3H), 1.20-1.18 
(m, 2H), 0.90-0.89 (m, 6H). 





1H NMR (CDCl3, 400MHz)  5.92 (br s, 1H), 3.71 (s, 2H), 3.51-3.46 (m, 2H), 3.13-




1H NMR (CDCl3, 400MHz)  5.91 (br s, 1H), 3.71 (s, 2H), 3.51-3.46 (m, 2H), 3.13-
3.09 (m, 2H), 2.55 (t, J = 7.4 Hz, 2H), 2.00 (s, 3H), 1.65-1.58 (m, 4H), 1.35-1.31 
(m, 2H), 0.93-0.91 (m, 3H). 
S-(2-acetamidoethyl) 3-oxodecanethioate: 
 
1H NMR (CDCl3, 400MHz)  5.90 (br s, 1H), 3.71 (s, 2H), 3.51-3.46 (m, 2H), 3.13-
3.10 (m, 2H), 2.55 (t, J = 7.4 Hz, 2H), 2.00 (s, 3H), 1.61 (m, 4H), 1.32-1.29 (m, 




1H NMR (CDCl3, 400MHz)  6.04 (br s, 1H), 3.68 (s, 2H), 3.50-3.44 (m, 2H), 3.11-




1H NMR (CDCl3, 400MHz)  6.00 (br s, 1H), 3.72 (s, 2H), 3.49-3.45 (m, 2H), 3.12-




1H NMR (CDCl3, 400MHz)  5.98 (br s, 1H), 3.71 (s, 2H), 3.49-3.45 (m, 2H), 3.12-
3.09 (m, 2H), 2.52 (t, J = 7.3 Hz, 2H), 1.99 (s, 3H), 1.62-1.53 (m, 3H), 1.20-1.18 
(m, 2H), 0.90-0.89 (m, 6H). 
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NMR spectrum of the intermediates and final compounds  
All (E)-S-(2-acetamidoethyl)alk-2-enethioate(enoyl-NAC) compounds were 
synthesized according to the general procedures as shown in Scheme1. 





































































































































































All S-(2-acetamidoethyl) 3-oxoalkanethioate (3-ketoacyl-NAC) compounds were 
synthesized according to the general procedures as shown in Scheme2. 






















































































































































4.0 Conclusions and recommendations for future work 
In summary, undecylprodiginine biosynthesis involves numerous intriguing 
enzymes and a fascinating interface with fatty acid biosynthesis. The overall 
objective of this study was to build a compressive understanding of the 
enzymology of both bacterial FAS and undecylprodiginine biosynthetic processes 
and the interface between them. 
Conclusion 1: In the current study kinetic analyses of the enzymes, which 
initiate fatty acid and prodiginine, biosynthesis in Streptomyces coelicolor using a 
range of different substrate pairings was carried out. Data demonstrates that 
RedP is specific for the straight chain acetyl-CoA, and FabH for the branched 
chain isobutyryl-CoA. The results also demonstrate the key role that acyl carrier 
protein specificity of these enzymes plays in keeping these two processes 
separate. Therefore FabH and its homolog RedP play an important role for 
efficient initiation of fatty acid and undecylprodiginine biosynthesis and serve as 
the first gate-keepers determining the type of fatty acids and prodiginines made in 
S. coelicolor 
Future work: RedR is proposed to catalyze condensation between an acyl-ACP 
with malonyl-ACP for undecylprodiginine biosynthesis in S. coelicolor and is 
homologous to the FabF, which catalyzes the same reaction during the 
elongation cycle of fatty acid biosynthesis (Cerdeno et. al 2002). The fabF gene 
is located within fatty acid biosynthetic genes cluster (Revill et. al 1995) and is 
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most likely responsible for catalyzing the elongation of both straight and 
branched-chain acyl-ACP substrates in streptomycetes (Fig. 5). The 
observations that plasmid-based expression of fabF in the SJM3 mutant 
increased overall production of prodiginine suggest that FabF can substitute for 
the role of RedR (Mo et. al; 2008), although FabF was less efficient and exerted 
less control than RedR in this role. Therefore RedR must have substrate 
specificity for elongation of straight-chain acyl-ACP (similar to the initiating 
enzyme RedP in aim 1), and this elongation process must terminate at an 
activated dodecanoic acid (Fig 5). However, the FabF catalyzed process would 
not be expected to terminate at this point. Given that branched-chain fatty acids 
predominant in streptomycetes, FabF might have preference for elongating 
branched-chain acyl-ACP (similar to the FabH in aim 1). Additionally similar to 
the initiating enzymes FabF and RedR) might have differing ACP specificity. Both 
of these enzymes have not yet been characterized in vivo. We cloned, express 
and tried to purify both FabF and RedR enzymes to characterize these enzymes 
with respect to substrate specificity. We were able to get pure FabF protein and 
to set up the assay conditions. However, we had difficulties in getting pure RedR 
protein and were not able to conduct these studies. Both of these enzymes need 
to be characterized in vitro. 
Conclusion 2: Kinetic analyses demonstrate that all three S. coelicolor enzymes 
(SCO1815, SCO1345 and SCO1346) have β-ketoacyl-reductase activity. 
Spectrophotometric and LC/MS assay demonstrated that FabG does not 
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differentiate between straight and branched chain substrates, and has equal 
preference for FabC and RedQ ACPs (except for SCO1345 for RedQ). Also, 
genes encoding β-ketoacyl-reductase enzymes are not present in the secondary 
metabolic gene cluster. These observations suggest that these enzymes are 
shared and process the intermediates in the elongation cycle of both fatty acid 
and undecylprodiginine biosynthesis. Surprisely, all three have β-ketoacyl-
reductase activity. Therefore it’s difficult to determine which ketoacyl-reductase is 
most relevant for S. coelicolor in vivo. Nevertheless, SCO1345 has less activity 
with FabC, and does not have any activity with RedQ. Additionally these 
enzymes have different cofactor preference; out of three SCO1815 and 
SCO1345 along with E. coli FabG have NADPH preference, in contrast to 
SCO1346, which has NADH preference. Furthermore, the SCO1815 gene lies 
directly adjacent to the SCO1814 gene (putative enoyl-ACP reductase) as is the 
case for the relevant in vivo enzyme in the other organism such as 
M.tuberculosis, M. smegmatis, S.griseous, and S. avermitilis. (Gago et. al., 2011) 
Conclusion 3: Spectrophotometric assay and LC/MS assay demonstrated that 
SCO1814 (InhA) has enoyl-ACP reductase activity. InhA is capable of utilizing 
various chain lengths of straight and branched chain substrates. Furthermore it 
does not discriminate between ACPs from primary metabolism and secondary 
metabolism. Also a gene encoding the enoyl-ACP reductase (FabI) required for 
converting enoyl-ACPs to acyl-ACPs is not present in the secondary metabolic 
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gene cluster. These observations demonstrate that SCO1814 is shared by both 
fatty acid and undecylprodiginine biosynthetic process in S. coelicolor. 
Future work: The missing piece of the FAS II system from S. coelicolor is a 
dehydratase. The enzyme encoded by fabA (or fabZ) is responsible for 
dehydration of 3-hydroxyacyl-ACP during the elongation cycles of the bacterial 
FAS-II. This gene has not been characterized in S. coelicolor. Therefore genetic 
analysis is required to identify the gene cluster containing the homologue of a 
FabA. The fabA gene encoding putative 3-hydroxyacyl-ACP dehydratase should 
be expressed, and the corresponding protein should be purified. Biochemical 
studies are required to elucidate the functional role and substrate specificity of S. 
coelicolor FabA. On the basis of our data (Aims 2 and 3) FabA should not have 
acyl and ACP specificity. According to our prediction FabA should not possess 
any acyl and ACP specificity similar to FabG and FabI (Aims 2 and 3) which will 









1. Kieser, T., Buttner, M. J., Chater, K. F., Bibb, M. J., Hopwood, D. A. (2000) 
Practical Streptomyces Genetics. Norwich, United Kingdom: The John Innes 
Foundation. 
2. Berdy. J., Horvath, I., and Szentirmai, A. (1964) Antibiotics produced by 
Streptomyces II. The tautomeric transformation of Xanthomycin. Z. Allg. 
Mikrobiol. 4, 232-235 
3. Hopwood, D. A., Chater, K. F., and Bibb, M. J., (1995) Genetics of antibiotic 
production in Streptomyces coelicolor A3(2), a model streptomycete. 
Biotechnology 28, 65-102 
4. Hopwood, D. A., (1989) Antibiotics: opportunities for genetic manipulation. 
Philos. Trans. R. Soc. Lond. B. Biol. Sci. 324, 549-562 
5. Hardisson, C, Manzanal, M. B., Salas, J. A., and Suarez, J. E., (1978) Fine 
structure, physiology and biochemistry of arthrospore germination in 
Streptomyces antibiotics. J. Gen. Microbiol. 2, 203-14 
6. Chater, K. F., (1989) Multilevel regulation of Streptomyces differentiation. 
Trends Genet. 5, 372-377. 
7. Magnuson, K., Jackowski, S., Rock, C. O., and Cronan, J. E. (1993) 
Regulation of fatty acid biosynthesis in Escherichia coli. Microbiol. Mol. Biol.  
Rev. 57, 522-542. 
8. Kaneda, T. (1991) Iso- and anteiso-fatty acids in bacteria: biosynthesis, 
function and taxonomic significance. Microbiol. Rev. 55, 288-302 
 103 
9. Wallace, K. K., Zhao, B., McArthur, H. A. I., and Reynolds, K. A. (1995) In vivo 
analysis of straight-chain and branched-chain fatty acid biosynthesis in three 
actinomycetes. FEMS Microbiol. Lett. 131, 227-234. 
10. Han, L., Lobo. S., and Reynolds, K. A. (1998) Characterization of β-ketoacyl-
acyl carrier protein synthase III from Streptomyces glaucescens and its role in 
initiation of fatty acid synthesis. J. Bacteriol. 180, 4481–4486. 
11. Kieser, H. M., Kieser, T, and Hopwood, D. A. (1992) A combined genetic and 
physical map of Streptomyces coelicolor A3(2) chromosome. J. Bacteriol. 
174, 5496-5507. 
12. Williamson, N. R., Fineran, P. C., Gristwood, T., Chawrai, S. R., Leeper, F. J., 
and Salmond, G. PC. (2007) Anticancer and immunosuppressive properties of 
bacterial prodiginines. Future. Microbial. 2, 605–618. 
13. Papireddy, K., Smilkstein, M., Kelly, J. X., Shweta. Salem, S. M , 
Alhamadsheh, M., Haynes, S. W., Challis, G. L., and Reynolds, K. A. (2011) 
Antimalarial activity of natural and synthetic prodiginines. J. Med. Chem.  54, 
5296–5306. 
14. Cerdeno, A. M., Bibb, M. J., and Challis, G. L. (2001) Analysis of the 
prodiginine biosynthesis gene cluster of Streptomyces coelicolor A3(2): new 
mechanisms for chain initiation and termination in modular multienzymes. 
Chem. Biol. 8, 817–829. 
15. Whicher JR, Florova G, Sydor P K, Singh R, Alhamadsheh MM, Challis G, 
Reynolds KA & Smith JL (2011) Structure and function of RedJ, a thioesterase 
 104 
from the prodiginine biosynthetic pathway in Streptomyces coelicolor. J. Biol. 
Chem 286: 22558–22569. 
16. Hopwood, D. A., and Sherman, D. H. (1990) Molecular genetics of polyketides 
and its comparision to fatty acid biosynthesis. Annu. Rev. Genet. 24, 37-66. 
17. Smith, D. S., Wood, N. J., and Hodgson, D. A. (1995) Interaction between 
primary and secondary metabolism in Streptomyces coelicolor A3(2): role of 
pyrroline-5-carboxylate dehydrogenase. Microbiology 141, 1739-1744. 
18. Florova, G., Kazanina, G., and Reynolds, K. A. (2002) Enzymes involved in 
fatty acid and polyketide biosynthesis in Streptomyces glaucescens: role of 
FabH and FabD and their acyl carrier protein specificity. Biochemistry 41, 
10461–10471 
19. Gago, G., Diacovich, L., Arabolaza, A., Tsai, S., and Gramajo, H. (2011). Fatty 
acid biosynthesis in actinomycetes. FEMS Microbiol. Rev. 35, 475-497. 
20. Heath RJ, White SW & Rock CO (2002) Inhibition of fatty acid synthesis as 
antimicrobial chemotherapeutics. Appl Microbiol Biotech 58: 695–703. 
21. Tsay JT, Oh W, Larson TJ, Jackowski S &  Rock CO (1992) Isolation and 
characterization of the β-ketoacyl-acyl carrier protein synthase III gene (fabH ) 
from Escherichia coli K-12. J Biol Chem 267: 6807–6814. 
22. Han L, Lobo S & Reynolds KA (1998) Characterization of β-ketoacyl-acyl 
carrier protein synthase III from Streptomyces glaucescens and its role in 
initiation of fatty acid synthesis. J Bacteriol 180: 4481–4486. 
 105 
23. Florova G, Kazanina G, & Reynolds KA (2002) Enzymes involved in fatty acid 
and polyketide biosynthesis in Streptomyces glaucescens: role of FabH and 
FabD and their acyl carrier protein specificity. Biochemistry 41: 10461–10471. 
24. Qiu X, Choudhry AE, Janson CA, Grooms M, Daines RA, Lonsdale JT & 
Khandekar SS (2005) Crystal structure and substrate specificity of the β-
ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus. 
Protein Sci 14: 2087–2094. 
25. Sachdeva S, Musayev FN, Alhamadsheh MM, Scarsdale JN, Wright HT, & 
Reynolds KA (2008) Separate entrance and exit portals for ligand traffic in 
Mycobacterium tuberculosis FabH. Chem Biol 15: 402–412. 
26. Li Y, Florova G & Reynolds KA (2005) Alternation of the fatty acid profile of 
Streptomyces coelicolor by replacement of the initiation enzyme 3-ketoacyl 
acyl carrier protein synthase III (FabH). J Bacteriol 187: 3795–3799. 
27. Bibb MJ, Sherman DH, Omura S & Hopwood DA (1994) Cloning, sequencing 
and deduced functions of a cluster of Streptomyces genes probably encoding 
biosynthesis of the polyketide antibiotic frenolicin. Gene 142: 31–39. 
28. Bililign T, Hyun CG, Williams JS, Czisny AM & Thorson JS (2004) The 
hedamycin locus implicates a novel aromatic PKS primary mechanism. Chem 
Biol 11: 959–969. 
29. Marti T, Hu Z, Pohl NL, Shah AN & Khosla C (2000) Cloning, nucleotide 
sequences and heterologous expression of the biosynthetic gene cluster for 
 106 
R1128, a non-steroidal estrogen receptor antagonist. Insight into an unusual 
priming mechanism. J Biol Chem 275: 33443–33448.  
30. Cerdeno AM, Bibb MJ & Challis GL (2001) Analysis of the prodiginine 
biosynthesis gene cluster of Streptomyces coelicolor A3(2): new mechanisms 
for chain initiation and termination in modular multienzymes. Chem Biol 8: 
817–829. 
31. Williamson NR, Fineran PC, Gristwood T, Chawrai SR, Leeper FJ & Salmond 
GPC (2007) Anticancer and immunosuppressive properties of bacterial 
prodiginines. Future microbiol 2: 605–618. 
32. Papireddy K, Smilkstein M, Kelly JX, Shweta, Salem SM, Alhamadsheh M, 
Haynes SW, Challis GL & Reynolds KA (2011) Antimalarial activity of natural 
and synthetic prodiginines. J Med Chem 54: 5296–5306. 
33. Mo S, Kim BS & Reynolds KA (2005) Production of branched-chain 
alkylprodiginines in S. coelicolor by replacement of the 3-ketoacyl ACP 
synthase III initiation enzyme, RedP. Chem Biol 12: 191–200. 
34. He X, Muller JP & Reynolds KA (2000) Development of a scintillation proximity 
assay for β-ketoacyl-acyl carrier protein synthase III. Anal Biochem 282: 107–
114. 
35. Lobo S, Florova G & Reynolds KA (2001) A Streptomyces collinus thiolase 
with novel acetyl-CoA: acyl carrier protein transacylase activity. Biochemistry 
40: 11955–11964. 
 107 
36. Whicher JR, Florova G, Sydor P K, Singh R, Alhamadsheh MM, Challis G, 
Reynolds KA & Smith JL (2011) Structure and function of RedJ, a thioesterase 
from the prodiginine biosynthetic pathway in Streptomyces coelicolor. J Biol 
Chem 286: 22558–22569. 
37. Revill WP, Bibb MJ & Hopwood DA (1996) Relationship between fatty acid and 
polyketide synthases from Streptomyces coelicolor A3(2): Characterization of 
the fatty acid synthase acyl carrier protein. J Bacteriol 178: 5660–5667. 
38. Mo S, Sydor PK, Corre C, Alhamadsheh MM, Stanley AE, Haynes SW, Song 
L, Reynolds KA, & Challis GL (2008) Elucidation of the Streptomyces 
coelicolor pathway to 2-undecylpyrrole, a key intermediate in 
undecylprodiginine and streptorubin B biosynthesis. Chem Biol 15: 137–148. 
39. Choi KH, Heath RJ & Rock CO (2000a) β-ketoacyl-acyl carrier protein 
synthase III (FabH) is a determining factor in branched-chain fatty acid 
biosynthesis. J Bacteriol 182: 365–370. 
40. Choi KH, Kremer L, Besra GS & Rock CO (2000b) Identification and substrate 
specificity of β-ketoacyl (acyl carrier protein) synthase III (mtFabH) from 
Mycobacterium tuberculosis. J Biol Chem 275: 28201–28207.  
41. Khandekar SS, Gentry DR, Van Aller GS, et al. (2001) Identification, substrate 
specificity, and inhibition of the Streptococcus pneumoniae β-ketoacyl-acyl 
carrier protein synthase III (FabH). J Biol Chem 276: 30025–30030.  
42. Brown AK, Sridharan S, Kremer L, Lindenberg S, Dover LG, Sacchetini JC & 
Besra GS (2005) Probing the mechanism of the Mycobacterium tuberculosis β-
 108 
ketoacyl-acyl carrier protein synthase III mtFabH: factors influencing catalysis 
and substrate specificity. J Biol Chem 280: 32539–32547. 
43. Heath RJ & Rock CO (1996) Inhibition of β-ketoacyl-acyl carrier protein 
synthase III (FabH) by acyl-acyl carrier protein in Escherichia coli. J Biol Chem 
271: 10996–11000 
44. Qiu X, Janson CA, Konstantinidis AK, Nwagwu S, Silverman C, Smith WW, 
Khandekar S, Lonsdale J & Abdul-Meguid SS (1999) Crystal structure of β-
ketoacyl-acyl carrier protein synthase III. A key condensing enzyme in bacterial 
fatty acid biosynthesis. J Biol Chem 274: 36465–36471. 
45. Davies C, Heath RJ, White SW & Rock CO (2000) The 1.8 Å crystal structure 
and active-site architecture of β-ketoacyl-acyl carrier protein synthase III 
(FabH) from Escherichia coli. Structure 8: 185–195. 
46. Han, L., Lobo. S., and Reynolds, K. A. (1998) Characterization of β-ketoacyl-
acyl carrier protein synthase III from Streptomyces glaucescens and its role in 
initiation of fatty acid synthesis. J. Bacteriol. 180, 4481–4486. 
47. Revill, W. P., Bibb, M. J., and Hopwood, D. A. (1996) Relationship between 
fatty acid and polyketide synthases from Streptomyces coelicolor A3(2): 
Characterization of the fatty acid synthase acyl carrier protein. J. Bacteriol. 
178, 5660–5667. 
48. Hopwood, D. A., (1989) Antibiotics: opportunities for genetic manipulation. 
Philos. Trans. R. Soc. Lond. B. Biol. Sci. 324, 549-562. 
 109 
49. Mchenney, M. A., Hosted, T. J., Dehoff, B. S., Rosteck, P. R., and Baltz, R. 
H., (1998) Molecular Cloning and Physical Mapping of the Daptomycin Gene 
Cluster from Streptomyces roseosporus. J. Biol. Chem. 180, 143-151. 
50. Bibb, M.J., Sherman, D.H., Omura, S., and Hopwood, D. A. (1994) Cloning, 
sequencing and deduced    functions of a cluster of Streptomyces genes 
probably encoding biosynthesis of the polyketide antibiotic frenolicin. Gene 
142, 31–39. 
51. Marti, T., Hu, Z., Pohl, N. L., Shah, A. N., and Khosla, C. (2000) Cloning, 
nucleotide sequences and heterologous expression of the biosynthetic gene 
cluster for R1128, a non-steroidal estrogen receptor antagonist. Insights into 
an unusual priming mechanism. J. Biol. Chem. 275, 33443–33448.  
52. Wyszynski, F. J., Hesketh A. R., Bibb, M. J., and Davis, B. G. (2010) 
Dissecting tunicamycin biosynthesis by genome mining: cloning and 
heterologous expression of a minimal gene cluster. Chem. Sci., 1, 581-589. 
53. Wyszynski, F. J., Lee, S.S., Yabe, T., Wang, H., Gomez-Escribann J. P., 
Bibb, M. J., Lee, S. J., Davies, G. J., and Davis, B. G., (2012) Biosynthesis of 
the tunicamycin antibiotics proceeds via unique exo-glycal intermediates. 
Nature Chemistry, 4, 539-546. 
54. Cerdeno, A. M., Bibb, M. J., and Challis, G. L. (2001) Analysis of the 
prodiginine biosynthesis gene cluster of Streptomyces coelicolor A3(2): new 
 110 
mechanisms for chain initiation and termination in modular multienzymes. 
Chem. Biol. 8, 817–829. 
55. Williamson, N. R., Fineran, P. C., Gristwood, T., Chawrai, S. R., Leeper, F. J., 
and Salmond, G. PC. (2007) Anticancer and immunosuppressive properties of 
bacterial prodiginines. Future. Microbial. 2, 605–618. 
56. Papireddy, K., Smilkstein, M., Kelly, J. X., Shweta. Salem, S. M , 
Alhamadsheh, M., Haynes, S. W., Challis, G. L., and Reynolds, K. A. (2011) 
Antimalarial activity of natural and synthetic prodiginines. J. Med. Chem.  54, 
5296–5306. 
57. Tsay, J. T., Oh, W., Larson, T. J., Jackowski, S., and Rock, C. O. (1992) 
Isolation and characterization of the β-ketoacyl-acyl carrier protein synthase III 
gene (fabH) from Escherichia coli K-12. J. Biol. Chem. 267, 6807–6814. 
58. Choi, K. H., Heath, R. J., and Rock, C. O. (2000) β-ketoacyl-acyl carrier 
protein synthase III (FabH) is a determining factor in branched-chain fatty acid 
biosynthesis. J. Bacteriol.  182, 365–370. 
59. Singh, R., Mo, S., Florova, G., and Reynolds, K. A. (2012) Streptomyces 
coelicolor RedP and FabH enzymes, initiating undecylprodiginine and fatty 
acid biosynthesis, exhibit distinct acyl-CoA and malonyl-acyl carrier protein 
substrate specificities. FEMS microbio. Lett. 328, 32-38.  
 111 
60. Florova, G., Kazanina, G., and Reynolds, K. A. (2002) Enzymes involved in 
fatty acid and polyketide biosynthesis in Streptomyces glaucescens: role of 
FabH and FabD and their acyl carrier protein specificity. Biochemistry 41, 
10461–10471. 
61. Gago, G., Diacovich, L., Arabolaza, A., Tsai, S., and Gramajo, H. (2011). 
Fatty acid biosynthesis in actinomycetes. FEMS Microbiol. Rev. 35, 475-497. 
62. Tang, Y., Lee, H. Y., Tang, Y., Kim, C-Y., Mathews, I., and Khosla, C. (2006) 
Structural and functional studies on SCO1815: A β-ketoacyl-acyl carrier 
protein reductase from Streptomyces coelicolor A3 (2). Biochemistry 45, 
14085-14093.  
63. Lobo, S., Florova, G., and Reynolds, K. A. (2001) A Streptomyces collinus 
thiolase with novel acetyl-CoA: acyl carrier protein transacylase activity. 
Biochemistry 40, 11955–11964. 
64. Whicher, J. R., Florova, G., Sydor, P. K., Singh, R., Alhamadsheh, M. M., 
Challis, G., Reynolds, K. A., and Smith, J. L. (2011) Structure and function of 
RedJ, a thioesterase from the prodiginine biosynthetic pathway in 
Streptomyces coelicolor. J. Biol. Chem. 286, 22558–22569. 
65. Smirnona, N., and Reynolds, K. A. (2001) Engineered fatty acid biosynthesis 
in Streptomyces by altered catalytic function of beta-keto-acyl carrier protein 
synthase III. J. Bacteriol. 183, 2335-2342. 
 112 
66. Bloch, K. (1977). Control mechanism for fatty acids biosynthesis in 
Mycobacterium smegmatis. Adv. Enzymol 45, 1-84. 
67. Marrakchi, H., Ducasse, S., Labesse, G., Montrozier, H., Margeat, E., 
Emorine, L., Charpentier, X., Daffe, M., and Quelmard, A. (2002) MabA 
(FabG1), a Mycobacterium tuberculosis protein involved in the long-chain fatty 
acid elongation system FAS-II. Microbiol., 148, 951-960. 
68. Patel, M. P., Liu, W.S, West, J., Tew, D., Meek, T. D. and Thrall, S. H. (2005) 
Kinetic and Chemical Mechanism of the fabG-Encoded Streptococcus 
pneumonia. Beta-ketoacyl-ACP reductase. Biochemistry 44, 16753-16765. 
69. Brown, A. K., Sridharan, S., Kremer, L., Lindenberg, S., Dover, L. G, 
Sacchetini, J. C, and Besra, G. S. (2005) Probing the mechanism of the 
Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein synthase III 
mtFabH: factors influencing catalysis and substrate specificity. J Biol Chem 
280: 32539–32547. 
70. Meluzzi, D., Zheng, W. H., Hensler, M., Nizet, V., and Dorrestein, P. C. (2008) 
Top-down mass spectrometry on low-resolution instruments: Characterization 
of phosphopantetheinylated carrier domains in polyketide and non-ribosomal 
biosynthetic pathways. Bioorg. Med. Chem. Lett. 18, 3107-3111. 
71. Berglert, H., Wallnert, P., Ebelingt, A., Leitingert, B., Fuchsbichlers, S., 
Aschaued, H., Kollenz, G., Hogenauert, G., and Turnowskyt, F. (1994). 
 113 
Protein EnvM Is the NADH-dependent Enoyl-ACP Reductase (FabI) of 
Escherichia coli.  J. Biol. Chem. 269, 5493-5496. 
72. Heath, R. J., and Rock, C. O. (1995) Enoyl-Acyl Carrier Protein Reductase 
(fabI) Plays a Determinant Role in Completing Cycles of Fatty Acid Elongation 
in Escherichia coli. J. Biol. Chem. 270, 26538-26542. 
73. Schiebel, J., Chang, A., Lu, H., Baxter, M. V., Tonge, P. J., and Kisker, C. 
(2012) Staphylococcus aureus FabI: Inhibition, Substrate Recognition and 
Potential Implications for In Vivo Essentiality. Structure 20, 802-813. 
74. Chang, A., Schiebel, J., Yu, W., Bommineni, G. R., Pan, P., Baxter, M. V., 
Khanna, A., Sotriffer, C. A., Kisker, C., Tonge, P. J. (2013) Rational 
optimization of drug-target residence time: insights from inhibitor binding to 
the Staphylococcus aureus FabI enzyme-product complex. Biochemistry 52, 
4217-4228. 
75. Heath, R. J., Su, N., Murphy, C. K., and Rock, C. O. (2000) The Enoyl-[acyl-
carrier-protein] Reductases FabI and FabL from Bacillus subtilis. J. Biol. 
Chem. 275, 40128-40133. 
 
